<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="pmc-domain-id">1860</journal-id><journal-id journal-id-type="pmc-domain">fcimb</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8446444</article-id><article-id pub-id-type="pmcid-ver">PMC8446444.1</article-id><article-id pub-id-type="pmcaid">8446444</article-id><article-id pub-id-type="pmcaiid">8446444</article-id><article-id pub-id-type="pmid">34540718</article-id><article-id pub-id-type="doi">10.3389/fcimb.2021.720789</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Cellular and Infection Microbiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Brokaw</surname><given-names initials="A">Alyssa</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="author-notes" rid="fn003">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/485456"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Furuta</surname><given-names initials="A">Anna</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="author-notes" rid="fn003">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1447292"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dacanay</surname><given-names initials="M">Matthew</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/955398"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rajagopal</surname><given-names initials="L">Lakshmi</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/867968"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Adams Waldorf</surname><given-names initials="KM">Kristina M.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref><xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/750871"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Center for Global Infectious Disease Research, Seattle Children&#8217;s Research Institute</institution>, <addr-line>Seattle, WA</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Global Health, University of Washington</institution>, <addr-line>Seattle, WA</addr-line>, <country>United States</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Obstetrics &amp; Gynecology, University of Washington</institution>, <addr-line>Seattle, WA</addr-line>, <country>United States</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Pediatrics, University of Washington</institution>, <addr-line>Seattle, WA</addr-line>, <country>United States</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Obstetrics and Gynecology, University of Washington and Sahlgrenska Academy, University of Gothenburg</institution>, <addr-line>Gothenburg</addr-line>, <country>Sweden</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Irina Burd, Johns Hopkins University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Raja Veerapandian, Texas Tech University Health Sciences Center El Paso, United States; Anbarasu Kumarasamy, Bharathidasan University, India</p></fn><corresp id="fn001">*Correspondence: Kristina M. Adams Waldorf, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:adamsk@uw.edu">adamsk@uw.edu</email>; Lakshmi Rajagopal, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:lakshmi.rajagopal@seattlechildrens.org">lakshmi.rajagopal@seattlechildrens.org</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Bacteria and Host, a section of the journal Frontiers in Cellular and Infection Microbiology</p></fn><fn fn-type="equal" id="fn003"><p>&#8224;These authors have contributed equally to this work and share first authorship</p></fn></author-notes><pub-date pub-type="epub"><day>03</day><month>9</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>11</volume><issue-id pub-id-type="pmc-issue-id">375431</issue-id><elocation-id>720789</elocation-id><history><date date-type="received"><day>05</day><month>6</month><year>2021</year></date><date date-type="accepted"><day>09</day><month>8</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>18</day><month>09</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2022-12-20 01:10:15.307"><day>20</day><month>12</month><year>2022</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2021 Brokaw, Furuta, Dacanay, Rajagopal and Adams Waldorf</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Brokaw, Furuta, Dacanay, Rajagopal and Adams Waldorf</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fcimb-11-720789.pdf"/><abstract><p>Group B streptococcus (GBS) is a gram-positive bacteria that asymptomatically colonizes the vaginal tract. However, during pregnancy maternal GBS colonization greatly predisposes the mother and baby to a wide range of adverse outcomes, including preterm birth (PTB), stillbirth, and neonatal infection. Although many mechanisms involved in GBS pathogenesis are partially elucidated, there is currently no approved GBS vaccine. The development of a safe and effective vaccine that can be administered during or prior to pregnancy remains a principal objective in the field, because current antibiotic-based therapeutic strategies do not eliminate all cases of invasive GBS infections. Herein, we review our understanding of GBS disease pathogenesis at the maternal-fetal interface with a focus on the bacterial virulence factors and host defenses that modulate the outcome of infection. We follow GBS along its path from an asymptomatic colonizer of the vagina to an invasive pathogen at the maternal-fetal interface, noting factors critical for vaginal colonization, ascending infection, and vertical transmission to the fetus. Finally, at each stage of infection we emphasize important host-pathogen interactions, which, if targeted therapeutically, may help to reduce the global burden of GBS.</p></abstract><kwd-group><kwd>group B streptococcus</kwd><kwd>bacteria</kwd><kwd>pregnancy</kwd><kwd>colonization</kwd><kwd>vagina</kwd><kwd>placenta</kwd><kwd>fetus</kwd><kwd>preterm birth</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Institute of Allergy and Infectious Diseases<named-content content-type="fundref-id">10.13039/100000060</named-content></funding-source><award-id rid="cn001">AI133976, AI145890, AI143265, AI152268, AI055396, AI007509</award-id></award-group><award-group><funding-source id="cn002">Eunice Kennedy Shriver National Institute of Child Health and Human Development<named-content content-type="fundref-id">10.13039/100009633</named-content></funding-source><award-id rid="cn002">HD098713</award-id></award-group><award-group><funding-source id="cn003">NIH Office of the Director<named-content content-type="fundref-id">10.13039/100000052</named-content></funding-source><award-id rid="cn003">OD010425</award-id></award-group></funding-group><counts><fig-count count="4"/><table-count count="1"/><equation-count count="0"/><ref-count count="168"/><page-count count="19"/><word-count count="10402"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Group B Streptococcus (GBS) (also called <italic toggle="yes">Streptococcus agalactiae</italic>) is a gram-positive, &#946;-hemolytic, and chain-forming bacterium that can asymptomatically colonize the human vaginal and gastrointestinal tracts. However, during pregnancy, GBS can become highly invasive and pathogenic to the fetus and mother, leading to adverse outcomes. Invasive GBS infections during pregnancy result in preterm birth (PTB), stillbirth, and fetal death. The fetus and neonate are highly susceptible to GBS, causing sepsis, pneumonia, and meningitis which, in severe cases, leads to long-lasting sequelae that can affect the child&#8217;s central nervous system and lung function (<xref rid="B14" ref-type="bibr">Bianchi-Jassir et al., 2017</xref>; <xref rid="B88" ref-type="bibr">Madrid et al., 2017</xref>; <xref rid="B135" ref-type="bibr">Seale et al., 2017b</xref>). In the mother, GBS infections can lead to maternal sepsis and postpartum endometritis (<xref rid="B59" ref-type="bibr">Hall et al., 2017</xref>). The complex pathogenesis of maternal and infant GBS infection arises due to the large arsenal of the bacterium&#8217;s virulence factors, which can vary widely across strains and undergo altered expression depending on the host niche. Some virulence factors are implicated in a single disease outcome, such as the role of HvgA in neonatal meningitis (<xref rid="B152" ref-type="bibr">Tazi et al., 2010</xref>). Other virulence factors are more broadly associated with GBS pathogenesis, including the hemolysin (also called &#946;-hemolysin/cytolysin) (<xref rid="B117" ref-type="bibr">Pritzlaff et al., 2001</xref>; <xref rid="B85" ref-type="bibr">Liu et al., 2004</xref>; <xref rid="B64" ref-type="bibr">Hensler et al., 2005</xref>; <xref rid="B84" ref-type="bibr">Lembo et al., 2010</xref>); the molecular basis of which is the GBS pigment, or granadaene and has direct cytotoxic effects against many types of host cells (<xref rid="B167" ref-type="bibr">Whidbey et al., 2013</xref>; <xref rid="B54" ref-type="bibr">Gendrin et al., 2015</xref>; <xref rid="B168" ref-type="bibr">Whidbey et al., 2015</xref>; <xref rid="B18" ref-type="bibr">Boldenow et al., 2016</xref>; <xref rid="B5" ref-type="bibr">Armistead et al., 2020a</xref>). Host-pathogen interactions that alter the balance between vaginal tract colonization and GBS invasive disease ascending into the uterus are beginning to be elucidated (<xref rid="B159" ref-type="bibr">Vornhagen et al., 2018a</xref>). Further investigation of the GBS bacterial factors enabling colonization of the vagina and invasive disease will facilitate the design of novel GBS prophylactics and treatments that directly target pathogenesis. In this review, we summarize the seminal studies and recent advances that define our understanding of GBS disease pathogenesis at the maternal-fetal interface, focusing on the interplay between bacterial virulence factors and host defenses that ultimately leads to GBS clearance or invasion.</p></sec><sec id="s2"><title>Methods</title><sec id="s2_1"><title>Search Strategy and Selection Criteria</title><p>To identify recent and seminal GBS research relating to maternal colonization, ascending infection, and fetal injury, literature searches were performed using Google Scholar and PubMed Central. Variants of the terms &#8220;pregnancy,&#8221; &#8220;preterm labor,&#8221; &#8220;premature,&#8221; &#8220;vaginal colonization,&#8221; &#8220;colonization,&#8221; &#8220;uterus,&#8221; &#8220;ascending infection,&#8221; &#8220;placenta,&#8221; &#8220;fetus,&#8221; &#8220;vaccine&#8221; were used in combination with &#8220;Group B Streptococcus&#8221; or &#8220;Streptococcus agalactiae.&#8221; The literature search was limited to articles published between 2014-2021. However, we used snowball searches of article reference list to identify studies that were seminal for recent work in the field, including work published prior to 2014.</p></sec></sec><sec id="s3"><title>GBS Epidemiology and Prophylactic Measures</title><sec id="s3_1"><title>Global Epidemiology of GBS Disease Outcomes</title><p>GBS colonizes the rectovaginal space in approximately 20-25% of women worldwide, with rates varying widely in different parts of the world (<xref rid="B134" ref-type="bibr">Seale et al., 2017a</xref>). In a meta-analysis that pooled estimates of GBS colonization from 85 countries, the prevalence of colonization varied between 7-14% in Central America and Asia to 35% in the Caribbean. Europe, North America, and Australia had similar prevalence rates of 15-20%. Interestingly, estimates in Africa varied widely with West and South Africa at 14 and 25%, respectively (<xref rid="B125" ref-type="bibr">Russell et al., 2017</xref>). Due to the asymptomatic nature of rectovaginal colonization, it is difficult to determine if the prevalence of GBS colonization is changing over time; however, there is evidence that invasive GBS infection of nonpregnant adults is increasing. Between 2008 to 2018 within the Active Bacterial Core surveillance network, the incidence of invasive GBS infection in nonpregnant individuals increased from 8.1 to 10.8 cases per 100,000 adults, representing 11.5% of the US population (<xref rid="B51" ref-type="bibr">Francois Watkins et al., 2019</xref>). These studies highlight that GBS contributes significantly to the global burden of disease, and in addition, emphasize that GBS rectovaginal colonization is common worldwide.</p><p>Although GBS vaginal colonization is asymptomatic in most women, it is of particular concern during pregnancy due to the significant risk for adverse fetal and neonatal outcomes (<xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>). Maternal GBS infection is a leading cause of infection-induced PTB and stillbirth (<xref rid="B134" ref-type="bibr">Seale et al., 2017a</xref>). Further, in 2015 more than 20 million neonates were exposed to maternal GBS out of 140 million live births worldwide, and half of neonates born to pregnant GBS-colonized women are estimated to themselves become colonized (<xref rid="B134" ref-type="bibr">Seale et al., 2017a</xref>). In a conservative analysis of international data from a single year, at least 90,000 infant deaths (&lt;3 months of age), 10,000 cases of disability in children, 57,000 fetal infections or stillbirths, and 3.5 million cases of PTB were attributed to GBS. A disproportionate burden of these GBS cases occurred in Africa, which accounts for 54% of annual GBS cases and 64% of all fetal and infant deaths (<xref rid="B134" ref-type="bibr">Seale et al., 2017a</xref>). In addition to its fetal and neonatal disease burden, GBS can cause serious maternal disease. Recently, it was estimated that there are at least 33,000 annual cases of maternal invasive GBS disease worldwide (<xref rid="B134" ref-type="bibr">Seale et al., 2017a</xref>). Another systematic literature review found that 0.38 women per 1,000 pregnancies experience invasive GBS disease with symptoms ranging from endocarditis or pneumonia to maternal death in severe cases (<xref rid="B59" ref-type="bibr">Hall et al., 2017</xref>). GBS invasive disease in pregnancy poses significant risks to both the fetus and mother.</p><fig id="f1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>GBS disease manifestations for mothers and fetuses. GBS is considered a commensal colonizer of the maternal vaginal tract, but ascension of GBS into the uterus can lead to adverse perinatal outcomes. GBS can invade the amniotic cavity and fetus to cause a variety of disease manifestations in the fetus (left panel), some of which can occur even with a limited infection of the placental chorioamniotic membranes. Maternal GBS invasive disease is more infrequent and can vary in severity (right panel); more severe outcomes tend to occur in the setting of chorioamniotic membrane rupture and/or with maternal co-morbidities that compromise the immune response.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcimb-11-720789-g001.jpg"/></fig><p>Importantly, the prevalence of maternal, fetal, and neonatal disease are likely underestimated. In low-income countries that have the highest rates of invasive GBS cases, the microbiological cause of sepsis, PTB, stillbirth, or death may not be recognized if cultures are not obtained or if formalized pre- or antenatal visits are inaccessible. In addition, policies for GBS screening are highly variable both geographically and across high, middle, and low income countries. Policies regarding screening generally fall into two categories: microbiological or risk-factor based screening. Microbiological screening, sometimes known as universal screening, tests all mothers at a specific gestational age. In contrast, risk-factor based screening is more cautious in that mothers are tested only if they present with symptoms of GBS invasive disease (such as preterm labor) or if they have a history of adverse pregnancy outcomes. Screening methods, however, are not necessarily consistent among nations with similar economic status; for example the United States performs universal microbiological screening by rectovaginal swab at 35-37 weeks gestation, while Sweden and the United Kingdom utilize risk-based screening (<xref rid="B82" ref-type="bibr">Le Doare et al., 2017</xref>). Mothers who test positive for GBS are generally administered intravenous antibiotics during labor, called intrapartum antibiotic prophylaxis (IAP). Unfortunately IAP policies also vary due to cost or rising concerns of antibiotic resistance. Discrepancies in both screening and antibiotic use can have drastic effects on GBS case counts and birth outcomes. When symptoms present only after delivery, cases may not be attributed to GBS until late in the clinical course. Subclinical cases that can still lead to lifelong complications may remain undetected and untreated, and may never be linked to GBS infection. Additionally, by the time symptoms present in the clinic it may be too late to intervene. Rapid and low-cost testing strategies that can be implemented in low-resource settings would likely allow for more accurate estimates of the GBS burden of disease, and might provide opportunities to reduce this burden through IAP intervention.</p></sec><sec id="s3_2"><title>GBS Serotypes and Capsule Polysaccharide-Based Vaccines</title><p>Many GBS virulence factors influence a strain&#8217;s ability to colonize or cause severe disease. One key virulence factor is the sialylated GBS capsular polysaccharide (CPS), first identified by Dr. Rebecca Lancefield in the 1930s (<xref rid="B80" ref-type="bibr">Lancefield, 1934</xref>). To date, there are ten known capsular serotypes (Ia, Ib, II-IX), although six account for 98% of GBS colonization worldwide (Ia, Ib, II-V) (<xref rid="B125" ref-type="bibr">Russell et al., 2017</xref>). These same serotypes cover over 99% of overall cases, including EOD and LOD (<xref rid="B101" ref-type="bibr">Nanduri et al., 2019</xref>). Not unlike colonization rates and disease burden, GBS serotype frequencies vary geographically. For example, 25% of colonizing strains are serotype III worldwide, but this serotype only accounts for up to 10% of cases in Asian and African countries. Other serotypes such as V-IX are more prevalent in Africa and Southern, South-Eastern, and Eastern Asia (<xref rid="B125" ref-type="bibr">Russell et al., 2017</xref>). In a meta-analysis, serotype Ia and III were linked to 31 and 27% of GBS maternal invasive cases, respectively (<xref rid="B59" ref-type="bibr">Hall et al., 2017</xref>), while fetal and neonatal disease was dominated by serotype III which was responsible for 62% of cases. Serotypes Ia, Ib, and V are also commonly associated with EOD and LOD, but their contribution is largely dwarfed by serotype III (<xref rid="B88" ref-type="bibr">Madrid et al., 2017</xref>).</p><p>Although the GBS capsule is involved in a variety of immune evasion mechanisms (<xref rid="B90" ref-type="bibr">Marques et al., 1992</xref>; <xref rid="B149" ref-type="bibr">Takahashi et al., 1999</xref>; <xref rid="B166" ref-type="bibr">Weiman et al., 2010</xref>; <xref rid="B156" ref-type="bibr">Uchiyama et al., 2019</xref>), the GBS CPS conjugated to an immunogenic protein carrier is a well-studied vaccine strategy. Vaccination of pregnant rats with CPS III conjugate reduced vaginal colonization, chorioamnionitis, and vertical transmission (<xref rid="B31" ref-type="bibr">Chiarot et al., 2018</xref>), spurring the examination of these vaccines in human clinical trials. In nonpregnant women, this vaccine induced heightened antibody responses and delayed vaginal and rectal acquisition of GBS (<xref rid="B65" ref-type="bibr">Hillier et al., 2019</xref>). A major limitation of CPS-based vaccines is the need to confer protection against multiple serotypes, and thus multivalent CPS vaccine strategies are of high interest. A Novartis/GSK trivalent vaccine (Novartis/GSK GBS3) comprised of CPS Ia/Ib/III conjugate is considered safe in pregnant women, elicited high maternal antibody titers and the antibodies were placentally transferred to infants (<xref rid="B147" ref-type="bibr">Swamy et al., 2020</xref>). Unfortunately, a trivalent vaccine still does not include all clinically-relevant serotypes and could lead to selection of non-vaccine strains through capsule switching, a phenomenon that has been observed in many high-risk populations and among ST-17 strains (<xref rid="B12" ref-type="bibr">Bellais et al., 2012</xref>; <xref rid="B95" ref-type="bibr">Meehan et al., 2014</xref>; <xref rid="B102" ref-type="bibr">Neemuchwala et al., 2016</xref>; <xref rid="B100" ref-type="bibr">Nagano et al., 2019</xref>). Further, a recent study identified patients that were co-infected by multiple GBS serotypes at once (<xref rid="B71" ref-type="bibr">Jisuvei et al., 2020</xref>), which may enable capsule switching. Thus, a hexavalent CPS conjugate vaccine derived from serotypes Ia, Ib, II, III, IV, and V would cover more clinically-relevant strains (<xref rid="B13" ref-type="bibr">Bianchi-Jassir et al., 2020</xref>). A hexavalent CPS conjugate vaccine (Pfizer GBS6) induced the production of opsonophagocytic antibodies in vaccinated rhesus macques and protected murine infant pups from lethal GBS challenge upon maternal vaccination (<xref rid="B25" ref-type="bibr">Buurman et al., 2019</xref>). This Pfizer GBS6 vaccine was also well-tolerated in healthy adults and induced high antibody titers (<xref rid="B1" ref-type="bibr">Absalon et al., 2021</xref>), but its immunogenicity and efficacy has not been examined in clinical trials in pregnant women. Compared to whole CPS-based vaccines that are difficult to produce, an alternative strategy might utilize a more specific CPS epitope that can be chemically synthesized. One group has utilized X-ray crystallography and epitope mapping to design a synthetic CPS III glycan-conjugate vaccine (<xref rid="B97" ref-type="bibr">Michon et al., 2006</xref>; <xref rid="B27" ref-type="bibr">Carboni et al., 2017</xref>; <xref rid="B28" ref-type="bibr">Carboni et al., 2020</xref>), which appears to confer similar levels of protection to whole CPS conjugate (<xref rid="B106" ref-type="bibr">Oldrini et al., 2020</xref>). However, to address the challenge of capsule switching, highly technical and intensive X-ray crystallography studies would be needed to identify relevant epitopes for the other CPS types. A more recent development that might simplify this problem is the production of GBS strains that express chimeric CPS. In a mouse model, maternal vaccination with a chimeric CPS V/IX conjugate resulted in the protection of pups from infection by GBS serotypes V or IX (<xref rid="B26" ref-type="bibr">Campisi et al., 2021</xref>). Owing to the limited immunogenicity of CPS, the difficulty of attaining serotype coverage, and challenges related to CPS manufacturing, other virulence factors may serve as better or alternate vaccine targets.</p></sec><sec id="s3_3"><title>GBS Sequence Types and Virulence Factor Epidemiology</title><p>Aside from its serotype distinction, GBS can also be clustered genetically through a technique known as multi-locus sequence typing. This is performed by sequencing seven housekeeping genes for any GBS strain-of-interest, and the combination of these seven genomic loci generates a sequence type (ST) (sometimes called clonal complex or CC) (<xref rid="B72" ref-type="bibr">Jones et al., 2003</xref>). Among a global and ecologically diverse sample of strains, four major sequence types were found, ST-1, ST-17, ST19, and ST23 (<xref rid="B72" ref-type="bibr">Jones et al., 2003</xref>). Of these, ST-1 and ST-19 were largely associated with asymptomatic carriage, ST-23 was common among both asymptomatic carriers and invasive disease cases, and ST-17 serotype III strains were attributed to neonatal invasive infections (<xref rid="B72" ref-type="bibr">Jones et al., 2003</xref>). In contrast, a study of 225 invasive isolates from Taiwan implicated both ST-1 and ST-17 as invasive isolates causing maternal and neonatal disease (<xref rid="B155" ref-type="bibr">Tsai et al., 2019</xref>). Importantly, ST-17 strains are emerging internationally and are associated with an increased propensity for neonatal meningitis and antibiotic resistance (<xref rid="B152" ref-type="bibr">Tazi et al., 2010</xref>; <xref rid="B153" ref-type="bibr">Teatero et al., 2016</xref>; <xref rid="B73" ref-type="bibr">Kao et al., 2019</xref>). However, antibiotic resistance is also emerging among non-ST-17 strains (<xref rid="B60" ref-type="bibr">Hays et al., 2016</xref>). This increase in antibiotic resistance poses a significant threat, as IAP is currently the only FDA-approved GBS treatment for pregnant women and the only preventative measure against vertical transmission of GBS. Hypervirulent strains, including ST-17, have also recently been isolated from tilapia (<xref rid="B47" ref-type="bibr">Evans et al., 2009</xref>; <xref rid="B30" ref-type="bibr">Chen, 2019</xref>), and there are rising concerns that tilapia-adapted GBS might serve as a zoonotic route for human transmission (<xref rid="B145" ref-type="bibr">Sun et al., 2016</xref>). These challenges emphasize important gaps in screening for antibiotic resistant isolates, which could inform intrapartum antibiotic prophylaxis. In addition, hypervirulent ST-17 GBS may have emerged in humans following zoonotic transmission from cows (<xref rid="B15" ref-type="bibr">Bisharat et al., 2004</xref>), and thus improved GBS surveillance among animal reservoirs might provide insight into the emergence of clinically significant isolates and consequent challenges.</p></sec></sec><sec id="s4"><title>GBS Vaginal Colonization and Persistence</title><sec id="s4_1"><title>Maternal GBS Colonization Is a Risk Factor for Subsequent Disease</title><p>During infection of the maternal-fetal interface, GBS first encounters the maternal rectovaginal tract. In fact, one of the best-defined risk factors for fetal or neonatal adverse outcomes is maternal colonization (<xref rid="B14" ref-type="bibr">Bianchi-Jassir et al., 2017</xref>). Although only about 25% of women are colonized (<xref rid="B125" ref-type="bibr">Russell et al., 2017</xref>), GBS is often considered a member of the host microbiota because carriage is usually asymptomatic. However, temporal carriage of vaginal GBS can be incredibly variable; wherein one patient may be persistently colonized whereas another may experience recurring or intermittent colonization (<xref rid="B23" ref-type="bibr">Brzychczy-Wloch et al., 2014</xref>; <xref rid="B142" ref-type="bibr">Sroka-Oleksiak et al., 2020</xref>). Additional studies are needed to understand how colonization varies temporally and across populations, particularly among pregnant and nonpregnant women. Current findings suggest that vaginal colonization is regulated by many overlapping bacterial and host factors. Gastrointestinal and rectal GBS colonization are likely to modulate maternal colonization by directly seeding GBS into the vaginal tract (<xref rid="B96" ref-type="bibr">Meyn et al., 2009</xref>). For this review, we will focus on vaginal colonization as this location is the primary source of GBS that can lead to maternal-fetal disease. Unless otherwise specified, GBS colonization or carriage refers to that within the vaginal tract.</p></sec><sec id="s4_2"><title>Interactions Between the Vaginal Microbiome and GBS Are Complex</title><p>The vaginal microbiota is composed of a wide array of taxa that varies geographically, by racial or ethnic group, throughout the menstrual cycle, and during pregnancy (<xref rid="B142" ref-type="bibr">Sroka-Oleksiak et al., 2020</xref>). Many taxa, including <italic toggle="yes">Prevotella bivia</italic>, <italic toggle="yes">Veillonella</italic> spp., <italic toggle="yes">Eubacterium siraeum</italic>, and <italic toggle="yes">Staphylococcus</italic> spp. have been associated with GBS vaginal colonization in nonpregnant women. In contrast, bacterial vaginosis (BV)-associated bacterium 1 and 2, <italic toggle="yes">Prevotella</italic> genogroups 3 and 4, <italic toggle="yes">Dialister</italic> species type 2, and <italic toggle="yes">Megasphaera</italic> species type 1 are associated with a lack of GBS (<xref rid="B124" ref-type="bibr">Rosen et al., 2017</xref>). Many of these latter taxa are associated with bacterial vaginosis (BV), a heterogeneous vaginal microbial dysbiosis (<xref rid="B109" ref-type="bibr">Onderdonk et al., 2016</xref>). However, a recent small study of nonpregnant Chinese women observed increased <italic toggle="yes">Prevotella</italic> and <italic toggle="yes">Megasphaera</italic> spp. abundance among women who were GBS-colonized (<xref rid="B99" ref-type="bibr">Mu et al., 2019</xref>). Other studies using rats and mice have uncovered relationships between GBS colonization and the presence of BV-associated bacteria such as <italic toggle="yes">P. bivia</italic> (<xref rid="B34" ref-type="bibr">Cools et al., 2016</xref>) and <italic toggle="yes">Gardnerella vaginalis</italic> (<xref rid="B56" ref-type="bibr">Gilbert et al., 2021</xref>). Clearly, the relationships between GBS and other vaginal taxa are complicated. Conflicting findings across studies may be due in part to variation in vaginal microbiome composition, which is common across human cohorts and when comparing laboratory animals in different facilities; discrepancies in culturing and sequencing methods further complicates the comparison of such studies. Although majority of findings regarding GBS&#8217; interaction with other microbes are associative, GBS co-colonization with <italic toggle="yes">Candida albicans</italic> observed clinically (<xref rid="B34" ref-type="bibr">Cools et al., 2016</xref>) is supported mechanistically by observations of interaction between the GBS BspA adhesin and the <italic toggle="yes">C. albicans</italic> hyphae-specific surface protein Als3 (<xref rid="B119" ref-type="bibr">Rego et al., 2016</xref>). Whether the presence of any of these taxa alter GBS colonization rates in humans is unknown, as well as the mechanisms by which colonization may be altered. Future studies should interrogate changes in niche remodeling, nutrient availability and the immune environment that may occur alongside shifts in microbiome composition. It is possible that a combination of these factors contributes to the variable and fluctuating rates of GBS carriage.</p></sec><sec id="s4_3"><title>Vaginal Lactobacilli: Key Species That Limit GBS Colonization and Persistence</title><p>The healthy vaginal tract maintains an acidic pH due to the <italic toggle="yes">Lactobacillus</italic> species that metabolize glycogen and produce lactic acid (<xref rid="B21" ref-type="bibr">Boskey et al., 2001</xref>). In reproductive-age women, the microbiome can be categorized into 5 community state types (CSTs I-V) based on the dominating <italic toggle="yes">Lactobacillus</italic> species. Mechanisms by which Lactobacilli restrain GBS colonization at the microbiome-level remain unclear, but multiple studies have partially defined the interactions between different <italic toggle="yes">Lactobacillus</italic> species and GBS. Lactobacilli can have antagonistic effects on the growth of GBS and host cell interactions <italic toggle="yes">in vitro</italic> (<xref rid="B16" ref-type="bibr">Bodaszewska et al., 2010</xref>; <xref rid="B110" ref-type="bibr">Ortiz et al., 2014</xref>; <xref rid="B93" ref-type="bibr">Marziali et al., 2019</xref>; <xref rid="B63" ref-type="bibr">He et al., 2020</xref>). While in human observational vaginal microbiome studies, the relationship between <italic toggle="yes">Lactobacillus</italic>-replete microbiomes and GBS colonization is less clear (<xref rid="B76" ref-type="bibr">Kubota et al., 2002</xref>; <xref rid="B3" ref-type="bibr">Altoparlak et al., 2004</xref>; <xref rid="B37" ref-type="bibr">Daniel Johannes R&#246;nnqvist et al., 2006</xref>; <xref rid="B23" ref-type="bibr">Brzychczy-Wloch et al., 2014</xref>; <xref rid="B120" ref-type="bibr">Rick et al., 2017</xref>), there is evidence that reduced taxonomic diversity and <italic toggle="yes">Lactobacillus</italic> dominance are possible mechanisms of microbiome-based protection against GBS during pregnancy (<xref rid="B142" ref-type="bibr">Sroka-Oleksiak et al., 2020</xref>). An exception is CST IV, which encompasses a more diverse and dysbiotic assortment of non-<italic toggle="yes">Lactobacillus</italic> anaerobes accompanied by increased vaginal pH (<xref rid="B118" ref-type="bibr">Ravel et al., 2011</xref>). This CST can be further differentiated into IV-A and IV-B (<xref rid="B53" ref-type="bibr">Gajer et al., 2012</xref>), and CST IV-A has been linked to increased GBS risk and appears to be <italic toggle="yes">Streptococcus</italic> and <italic toggle="yes">Prevotella</italic>-dominant (<xref rid="B124" ref-type="bibr">Rosen et al., 2017</xref>; <xref rid="B22" ref-type="bibr">Brotman et al., 2018</xref>). These data suggest that Lactobacilli alone do not explain differences in GBS carriage status, although this genus likely affects GBS colonization in concert with other vaginal taxa. A better understanding of what promotes <italic toggle="yes">Lactobacillus</italic>-replete vaginal microbiomes during pregnancy is needed, and how these changes alter the vaginal environment including immune responses remains to be determined. Interestingly, a subset of specific pathogen-free mice appears to possess <italic toggle="yes">Lactobacillus</italic>-dominant vaginal flora that might more closely mimic that of the healthy human vagina. Preliminary evidence suggests that this murine CST may impair GBS persistence (<xref rid="B162" ref-type="bibr">Vrbanac et al., 2018</xref>). A mechanistic understanding of the environmental or genetic cues that culminate in the development of this human-like murine vaginal microbiome could allow for more relevant studies of GBS vaginal colonization and persistence in mice.</p></sec><sec id="s4_4"><title>GBS Adaptation in the Vaginal Tract Favor Virulence</title><p>GBS is frequently described as an opportunist or pathobiont due to its ability to transition from an asymptomatic colonizer to a potent pathogen (<xref rid="B7" ref-type="bibr">Armistead et al., 2019</xref>). During this transition, GBS must adapt to its new niche in order to successfully colonize and persist in the vaginal tract. Luckily, GBS encodes a plethora of two-component systems (TCS), each comprised of a sensor histidine kinase and DNA-binding response regulator (denoted by S and R, respectively), that grant the ability to respond to diverse environmental stimuli.</p><p>One well-studied GBS TCS, CovR/S (also known as CsrR/S), responds to low pH (<xref rid="B111" ref-type="bibr">Park et al., 2012</xref>), which is likely encountered in the healthy human vaginal tract. CovR/S is a master regulator of GBS virulence, and more than a hundred genes undergo transcriptional changes in response to CovR. Interestingly, one phenotype of GBS lacking this TCS (denoted as &#916;<italic toggle="yes">covRS</italic> or &#916;<italic toggle="yes">covR</italic>) is hyper-adhesion, which occurs due to increased expression of cell surface adhesins (<xref rid="B79" ref-type="bibr">Lamy et al., 2004</xref>; <xref rid="B111" ref-type="bibr">Park et al., 2012</xref>). CovR/S also regulates expression of the <italic toggle="yes">cyl</italic> operon (<xref rid="B69" ref-type="bibr">Jiang et al., 2005</xref>), which encodes factors required for the biosynthesis of GBS&#8217; characteristic hemolysin (<xref rid="B167" ref-type="bibr">Whidbey et al., 2013</xref>; <xref rid="B168" ref-type="bibr">Whidbey et al., 2015</xref>; <xref rid="B7" ref-type="bibr">Armistead et al., 2019</xref>; <xref rid="B5" ref-type="bibr">Armistead et al., 2020a</xref>). This virulence factor is a pro-inflammatory cytotoxin that is essential for many facets of GBS disease including pneumonia, sepsis, meningitis, PTB, and invasive infection of adults (<xref rid="B103" ref-type="bibr">Nizet et al., 1996</xref>; <xref rid="B104" ref-type="bibr">Nizet et al., 1997</xref>; <xref rid="B55" ref-type="bibr">Gibson et al., 1999</xref>; <xref rid="B42" ref-type="bibr">Doran et al., 2002</xref>; <xref rid="B43" ref-type="bibr">Doran et al., 2003</xref>; <xref rid="B64" ref-type="bibr">Hensler et al., 2005</xref>; <xref rid="B167" ref-type="bibr">Whidbey et al., 2013</xref>; <xref rid="B168" ref-type="bibr">Whidbey et al., 2015</xref>; <xref rid="B18" ref-type="bibr">Boldenow et al., 2016</xref>; <xref rid="B5" ref-type="bibr">Armistead et al., 2020a</xref>; <xref rid="B6" ref-type="bibr">Armistead et al., 2020b</xref>), and the pro-inflammatory nature of this factor is likely the reason hyperhemolytic GBS strains have reduced vaginal persistence (<xref rid="B54" ref-type="bibr">Gendrin et al., 2015</xref>; <xref rid="B112" ref-type="bibr">Patras et al., 2015</xref>). Another more recently characterized TCS that is important for GBS vaginal carriage is SaeR/S, which was identified by a transcriptomic screen using mice that were vaginally colonized with GBS. The SaeR/S system regulates the transcription of surface adhesin PbsP during murine vaginal colonization, and in fact <italic toggle="yes">pbsP</italic> is upregulated more than 250-fold during murine vaginal colonization and GBS lacking PbsP exhibit reduced vaginal persistence (<xref rid="B33" ref-type="bibr">Cook et al., 2018</xref>). While the extracellular signal recognized by SaeR/S is unknown, it is hypothesized to be a small peptide, potentially an antimicrobial peptide (AMP) present in the vaginal tract. Future studies should aim to establish the relevance of SaeR/S in human vaginal colonization and persistence, and define the roles of other SaeR-regulated factors.</p><p>In contrast to CovR/S and SaeR/S, other TCSs confer protection against host defenses encountered in the vaginal tract, prolonging GBS survival. DltR/S is involved in cell wall lipoteichoic acid (LTA) maintenance, and importantly, loss of this system alters LTA expression and increases GBS susceptibility to AMPs common in the reproductive tract (<xref rid="B115" ref-type="bibr">Poyart et al., 2001</xref>; <xref rid="B116" ref-type="bibr">Poyart et al., 2003</xref>). LiaR/S also allows evasion of antimicrobial defenses by regulating cell wall synthesis and cell membrane modification, permitting GBS to evade AMPs (<xref rid="B87" ref-type="bibr">Madanchi et al., 2020</xref>). Although these TCS may contribute to vaginal persistence, their roles have yet to be interrogated <italic toggle="yes">in vivo</italic>.</p></sec><sec id="s4_5"><title>GBS Factors That Facilitate Vaginal Adhesion and Persistence</title><p>GBS encodes numerous surface adhesins and invasins that interact with host epithelia and promote infection, although the data for some of these surface proteins is more convincing than for others. BspA, a member of the antigen I/II protein family, mediates binding to vaginal epithelial cells through interactions between its own V domain and the host gp340 surface receptor (<xref rid="B119" ref-type="bibr">Rego et al., 2016</xref>). Further, GBS surface &#946; protein has recently been shown to interact with epithelial CEACAM1 and 5 receptors (<xref rid="B158" ref-type="bibr">van Sorge et al., 2021</xref>), which are common in the vagina and uterus, respectively (<xref rid="B68" ref-type="bibr">Islam et al., 2018</xref>). As previously discussed, PbsP promotes GBS vaginal persistence in mice (<xref rid="B33" ref-type="bibr">Cook et al., 2018</xref>). Apart from direct binding to host epithelial cell receptors, GBS can also interact with host extracellular matrix (ECM) components. The serine-rich repeat glycoprotein Srr1 binds to keratin 4 or fibrinogen (<xref rid="B127" ref-type="bibr">Samen et al., 2007</xref>; <xref rid="B98" ref-type="bibr">Mistou et al., 2009</xref>; <xref rid="B138" ref-type="bibr">Sheen et al., 2011</xref>; <xref rid="B136" ref-type="bibr">Seo et al., 2013</xref>); in murine models, this interaction contributes to cervicovaginal persistence in a fibrinogen- and Srr1-latch domain-dependent manner (<xref rid="B164" ref-type="bibr">Wang et al., 2014</xref>). FbsC (also called BsaB) similarly binds the host ECM <italic toggle="yes">via</italic> laminin and fibrinogen to allow cervicovaginal adhesion of GBS (<xref rid="B111" ref-type="bibr">Park et al., 2012</xref>; <xref rid="B24" ref-type="bibr">Buscetta et al., 2014</xref>). Other surface proteins, such as pili, are also important during GBS colonization. For example, bacterial competition studies show that pilus-null GBS are outcompeted by an isogenic wild-type strain during vaginal colonization of mice (<xref rid="B138" ref-type="bibr">Sheen et al., 2011</xref>). Although some GBS surface proteins have not been studied extensively <italic toggle="yes">in vivo</italic>, the above factors appear have been directly linked to the vaginal tract.</p></sec><sec id="s4_6"><title>The Vaginal Immune Response Can Restrict GBS</title><p>GBS must also overcome the vaginal immune response in order to achieve persistent colonization. Vaginal tract colonization induces the recruitment of numerous immune cells, which can facilitate bacterial clearance through diverse mechanisms (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>, vaginal tract). The production of IL-1&#946;, IL-6, IL-8, IL-23, IL-17, IFN-&#947;, and TNF-&#945; are associated with reduced GBS colonization (<xref rid="B113" ref-type="bibr">Patras et al., 2013</xref>; <xref rid="B29" ref-type="bibr">Carey et al., 2014</xref>; <xref rid="B112" ref-type="bibr">Patras et al., 2015</xref>; <xref rid="B148" ref-type="bibr">Sweeney et al., 2020</xref>). These proinflammatory mediators are primarily produced by neutrophils recruited through IL-8, CXCL1, and CXCL2 (<xref rid="B113" ref-type="bibr">Patras et al., 2013</xref>; <xref rid="B29" ref-type="bibr">Carey et al., 2014</xref>; <xref rid="B112" ref-type="bibr">Patras et al., 2015</xref>), macrophages (<xref rid="B29" ref-type="bibr">Carey et al., 2014</xref>), and vaginal epithelial cells (<xref rid="B113" ref-type="bibr">Patras et al., 2013</xref>). In addition, vagina-resident mast cells contribute to GBS clearance through the hemolysin-induced release of pre-formed inflammatory mediators, including histamine (<xref rid="B54" ref-type="bibr">Gendrin et al., 2015</xref>). However, the roles of natural killer and dendritic cells (DCs) in vaginal immune responses are incompletely understood. In mice, vaginal clearance is associated with Th1, Th2, and Th17 responses (<xref rid="B29" ref-type="bibr">Carey et al., 2014</xref>; <xref rid="B112" ref-type="bibr">Patras et al., 2015</xref>). Studies using B cell-deficient or neonatal Fc receptor-null mice suggest mucosal B cells are involved in the clearance of vaginal GBS (<xref rid="B9" ref-type="bibr">Baker et al., 2017</xref>). Further, increases in serotype-specific anti-CSP antibody titers and opsonophagocytic activity (OPA) correlate with reduced colonization rates (<xref rid="B77" ref-type="bibr">Kwatra et al., 2015</xref>). Importantly, multiple studies have identified strain-level differences in immune responses that may partially explain differences in strain and serotype colonization of the vagina (<xref rid="B112" ref-type="bibr">Patras et al., 2015</xref>; <xref rid="B148" ref-type="bibr">Sweeney et al., 2020</xref>).</p><fig id="f2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>GBS-directed host immune responses at the maternal-fetal interface. During GBS infection at the maternal-fetal interface, a variety of immune cell interactions can occur. In the vaginal tract, epithelial cells exposed to hyperhemolytic (HH) GBS secrete C-X-C motif chemokine ligand 2 (CXCL2) and interleukin (IL)-8 which mediate GBS elimination through the recruitment of neutrophils (<xref rid="B113" ref-type="bibr">Patras et al., 2013</xref>). Whereas wild-type GBS colonize the lower genital tract in the presence of mast cells, HH GBS induce mast cell degranulation in a hemolysin and calcium-dependent manner. This results in the release of pre-formed mast cell mediators, such as eicosanoids and histamine that mediate GBS clearance (<xref rid="B54" ref-type="bibr">Gendrin et al., 2015</xref>). During ascending infection, cervical Th17 cells that produce IL-17 are associated with GBS clearance (<xref rid="B112" ref-type="bibr">Patras et al., 2015</xref>). Decidual stromal cells exposed to GBS produce prostaglandin E<sub>2</sub> (PGE<sub>2</sub>), which suppresses macrophage tumor necrosis factor alpha (TNF-&#945;) production (<xref rid="B121" ref-type="bibr">Rogers et al., 2018</xref>). Placental neutrophils produce neutrophil extracellular traps (NETs) that immobilize GBS and facilitate clearance <italic toggle="yes">via</italic> phagocytosis and nutritional immunity. NET-contained lactoferrin sequesters ferric iron (Fe<sup>3+</sup>), resulting in GBS growth arrest (<xref rid="B75" ref-type="bibr">Kothary et al., 2017</xref>). HH GBS evade placental NETs by hemolysin-mediated killing of neutrophils (<xref rid="B18" ref-type="bibr">Boldenow et al., 2016</xref>). Macrophages control placental GBS replication through a similar mechanism, and macrophage extracellular traps (METs) contain similar products (<xref rid="B45" ref-type="bibr">Doster et al., 2018</xref>). Finally, neutrophils in maternal and cord blood phagocytose GBS and produce reactive oxygen species (ROS) to mediate bacterial killing. However, GBS expressing hyaluronidase (HylB) inhibit this mechanism by interfering with toll-like receptor 2 and 4 signaling. Downstream effects of this immune dampening suppress ROS production and facilitate GBS survival (<xref rid="B32" ref-type="bibr">Coleman et al., 2021</xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcimb-11-720789-g002.jpg"/></fig></sec><sec id="s4_7"><title>Novel Prophylactics to Prevent Vaginal Colonization</title><p>The ability to prevent maternal vaginal colonization would eliminate a significant proportion of GBS morbidity and mortality. GBS interactions in the vaginal tract highlight important bottlenecks and are defined by specific host-pathogen interactions that could be targeted by therapeutics. Although CPS conjugate vaccination is correlated with reductions in GBS carriage, serotype coverage and capsule switching are still major concerns. Thus, the development of other novel strategies remains a priority.</p><p>The vaginal microbiome is malleable, and therefore therapies capable of inducing changes in composition might successfully restrict or eliminate GBS. Although it remains unclear whether Lactobacilli inhibit GBS colonization <italic toggle="yes">in vivo</italic>, probiotic <italic toggle="yes">Lactobacillus</italic> species have potential as a novel therapeutic. In mice, serial vaginal inoculation with probiotic <italic toggle="yes">L. reuteri</italic> CRL1324 confers partial protection against GBS, and this effect is mediated at least in part by mucosal immunity (<xref rid="B38" ref-type="bibr">De Gregorio et al., 2015</xref>; <xref rid="B39" ref-type="bibr">De Gregorio et al., 2016</xref>). Human clinical trials for oral probiotic Lactobacilli are also encouraging. A small randomized controlled trial found that administration of <italic toggle="yes">L. rhamnosus</italic> GR-1 and <italic toggle="yes">L. reuteri</italic> RC-14 during the third trimester reduced GBS rectovaginal colonization rates at delivery (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT01577108">NCT01577108</ext-link>) (<xref rid="B67" ref-type="bibr">Ho et al., 2016</xref>). In another study, the same probiotics reduced the abundance of vaginal GBS and BV-associated taxa (<xref rid="B86" ref-type="bibr">Liu et al., 2020</xref>). In addition, the probiotic <italic toggle="yes">L. salivarius</italic> CECT9145 also reduced GBS rectovaginal colonization during pregnancy (<xref rid="B91" ref-type="bibr">Mart&#237;n et al., 2019</xref>). Though these studies sound promising, others have observed no protective effect (Farr &#8211; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03008421">NCT03008421</ext-link>, Sharpe &#8211; SCRD42020216531) (<xref rid="B108" ref-type="bibr">Olsen et al., 2018</xref>; <xref rid="B48" ref-type="bibr">Farr et al., 2020</xref>; <xref rid="B137" ref-type="bibr">Sharpe et al., 2021</xref>), and thus larger studies are required to confirm efficacy. It is also worth noting that due to differences in vaginal CST and microbiome composition, probiotics may not serve as a universal prophylactic against GBS. Furthermore, it is unknown how stable or long-lasting probiotic-induced changes to the microbiome are. As such, it is essential that follow-up studies are performed across international cohorts and in combination with substantial characterization of the vaginal microbiome to better inform the effects of oral probiotic use.</p><p>GBS utilizes many surface adhesins and invasins during the vaginal colonization stage, which have been targeted by vaccines (<xref rid="T1" ref-type="table"><bold>Table 1</bold></xref>). Maternal vaccination with a chimeric protein derived from six variants of the pilus type 2a backbone subunit (6xD3) resulted in protection of neonates against lethal challenge with GBS that carry type 2a pili (<xref rid="B105" ref-type="bibr">Nuccitelli et al., 2011</xref>); however, vaginal colonization was not interrogated. A similar mouse model determined that maternal vaccination with a C5a peptidase-containing vaccine protected neonates against lethal challenge and, furthermore, prevented subsequent vaginal colonization of the dam (<xref rid="B129" ref-type="bibr">Santillan et al., 2008</xref>; <xref rid="B130" ref-type="bibr">Santillan et al., 2011</xref>). BibA also holds promise as a vaccine, as mucosal vaccination with recombinant BibA resulted in protection of mice against both systemic and vaginal challenge (<xref rid="B44" ref-type="bibr">dos Santos et al., 2020</xref>). Moreover, this vaccine also conferred protection to neonatal mice in a maternal vaccination model (<xref rid="B128" ref-type="bibr">Santi et al., 2009</xref>). These studies highlight that adhesin-based vaccines are encouraging, although these strategies are more nascent than CPS conjugate vaccines and thus many remain in preclinical stages. Even so, these vaccines are not without limitations. A major challenge in targeting adhesins is their functional redundancy, and thus future studies need to test which adhesins are dispensable <italic toggle="yes">in vivo</italic> and which are not. In addition, while the surface adhesins are better conserved than CPS, GBS adhesins may vary by strain or across ST lineages. Consequently, adhesin-based strategies may still need to target multiple GBS factors in order to prevent colonization by all relevant strains. Despite this limitation, novel vaccines utilizing GBS adhesins and invasins antigens warrant future investigation in clinical trials, and should be considered as an attractive alternative to CPS-based vaccines.</p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Novel in-pipeline vaccines that target GBS determinants of vaginal colonization and invasive disease.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">GBS Bacterial Factor</th><th valign="top" align="center" rowspan="1" colspan="1">Role in Pathogenesis</th><th valign="top" align="center" rowspan="1" colspan="1">Vaccine</th><th valign="top" align="center" rowspan="1" colspan="1">Study Design*</th><th valign="top" align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td valign="top" rowspan="4" align="left" colspan="1">Capsule</td><td valign="top" rowspan="4" align="left" colspan="1">Immune evasion at varied stages of infection</td><td valign="top" align="left" rowspan="1" colspan="1">Novartis/GSK GBS3</td><td valign="top" align="left" rowspan="1" colspan="1">Human (phase II: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02046148">NCT02046148</ext-link>)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B147" ref-type="bibr">Swamy et al., 2020</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pfizer GBS6</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse (maternal vaccination);<break/>Rhesus macaque (no challenge);<break/>Human (phase I/II: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03170609">NCT03170609</ext-link>)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B25" ref-type="bibr">Buurman et al., 2019</xref>; <xref rid="B1" ref-type="bibr">Absalon et al., 2021</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Synthetic CPS III glycan conjugate</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse (no challenge)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B28" ref-type="bibr">Carboni et al., 2020</xref>; <xref rid="B106" ref-type="bibr">Oldrini et al., 2020</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chimeric CPS V/IX conjugate</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse (maternal vaccination)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B26" ref-type="bibr">Campisi et al., 2021</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pilus</td><td valign="top" align="left" rowspan="1" colspan="1">Adhesion to vaginal epithelium</td><td valign="top" align="left" rowspan="1" colspan="1">6x3D</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse (maternal vaccination)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B105" ref-type="bibr">Nuccitelli et al., 2011</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">C5a peptidase</td><td valign="top" align="left" rowspan="1" colspan="1">Complement evasion in blood;<break/>Attachment to fibronectin</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Mouse (maternal vaccination)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B129" ref-type="bibr">Santillan et al., 2008</xref>; <xref rid="B130" ref-type="bibr">Santillan et al., 2011</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BibA</td><td valign="top" align="left" rowspan="1" colspan="1">Complement evasion in blood;<break/>Adhesion to cervical epithelium</td><td valign="top" align="left" rowspan="1" colspan="1">Recombinant BibA with varied adjuvants</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse (maternal vaccination);<break/>Mouse (parenteral and mucosal vaccination with vaginal or lethal challenge)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B128" ref-type="bibr">Santi et al., 2009</xref>; <xref rid="B44" ref-type="bibr">dos Santos et al., 2020</xref>)</td></tr><tr><td valign="top" rowspan="2" align="left" colspan="1">SIP</td><td valign="top" rowspan="2" align="left" colspan="1">Immunogenic protein</td><td valign="top" align="left" rowspan="1" colspan="1">Recombinant SIP with varied adjuvants</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse (parenteral and mucosal maternal vaccination)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B92" ref-type="bibr">Martin et al., 2002</xref>; <xref rid="B141" ref-type="bibr">Soto et al., 2019</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SIP-expressing <italic toggle="yes">Lactococcus lactis</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Mouse (mucosal vaccination)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B40" ref-type="bibr">Diaz-Dinamarca et al., 2020</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Alpha-like proteins</td><td valign="top" align="left" rowspan="1" colspan="1">Cervical cell invasion</td><td valign="top" align="left" rowspan="1" colspan="1">GBS-NN/NN2</td><td valign="top" align="left" rowspan="1" colspan="1">Mouse (maternal vaccination);<break/>Human (phase I nonpregnant: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02459262">NCT02459262</ext-link>; phase I pregnant: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04596878">NCT04596878</ext-link>)</td><td valign="top" align="left" rowspan="1" colspan="1"> (<xref rid="B143" ref-type="bibr">St&#229;lhammar-Carlemalm et al., 2007</xref>; <xref rid="B50" ref-type="bibr">Fischer et al., 2021</xref>)</td></tr></tbody></table><table-wrap-foot><fn><p>*All vaccinations utilized parenteral routes, unless specified as mucosal.</p></fn></table-wrap-foot></table-wrap><p>Finally, vaccine strategies that target GBS factors important for vaginal colonization should consider the route of administration as mucosal immunizations may better direct immune response to relevant tissue sites. Intranasal immunization of ethanol-killed whole GBS generated both robust systemic and mucosal responses and enhanced GBS clearance from the vaginal tract. In contrast, intramuscular immunization promoted systemic and mucosal antibodies response, but there was no difference in GBS vaginal colonization between vaccinated and control mice (<xref rid="B9" ref-type="bibr">Baker et al., 2017</xref>). Additionally, studies on the exceptionally well-conserved surface immunogenic protein (SIP) highlight important lessons for GBS vaccination. First, parenteral or mucosal vaccination of dams with recombinant SIP led to neonatal protection from GBS invasive disease (<xref rid="B92" ref-type="bibr">Martin et al., 2002</xref>). Second, a subcutaneous vaccination of SIP with AbISCO-100 adjuvant resulted in both humoral and cellular responses that protected against GBS vaginal colonization, whereas the vaccine adjuvanted with aluminum hydroxide resulted in only a weak humoral response. Serum or T cell transfer from vaccinated mice significantly reduced vaginal GBS burden in na&#239;ve mice, with T cells showing slightly higher efficacy than serum (<xref rid="B141" ref-type="bibr">Soto et al., 2019</xref>). This study emphasizes the importance of novel adjuvants in the formulation of a successful vaccine. Finally, mucosal vaccination may be more effective in stimulating immune cells in the vaginal tract; however, mucosal delivery is challenging. A third study by this group demonstrated a novel use for <italic toggle="yes">Lactococcus lactis</italic> as a delivery system for recombinant SIP, which again resulted in a strong humoral and cellular response that aided in vaginal clearance (<xref rid="B40" ref-type="bibr">Diaz-Dinamarca et al., 2020</xref>). GBS vaccines targeting SIP with an optimized adjuvant represent a promising platform to reduce GBS vaginal colonization.</p></sec></sec><sec id="s5"><title>GBS Ascending Infection</title><sec id="s5_1"><title>Ascension Of GBS From the Vaginal Tract May Require Transient Interaction With the Cervix</title><p>Most pathogens that cause intra-amniotic infections are vaginal tract commensals, highlighting the importance of ascending infection as a mechanism of invasive disease during pregnancy (<xref rid="B160" ref-type="bibr">Vornhagen et al., 2016</xref>; <xref rid="B159" ref-type="bibr">Vornhagen et al., 2018a</xref>; <xref rid="B123" ref-type="bibr">Romero et al., 2019</xref>). As a nonmotile bacterium, it is puzzling that GBS is able to ascend from the colonized vagina to the uterus. However, multiple mechanisms have been implicated in this stage of infection. GBS can promote the loss of vaginal epithelial barrier function by stimulating vaginal exfoliation (<xref rid="B159" ref-type="bibr">Vornhagen et al., 2018a</xref>). Additionally, GBS can interact with epithelial cells of the cervix using its diverse adhesins and invasins. Thus, cervical cell adhesion and invasion may promote GBS ascending infection into the uterus. Some adhesins, such as FbsC and Srr1, exhibit redundant function in the vagina and cervix (<xref rid="B24" ref-type="bibr">Buscetta et al., 2014</xref>; <xref rid="B70" ref-type="bibr">Jiang and Wessels, 2014</xref>; <xref rid="B164" ref-type="bibr">Wang et al., 2014</xref>). In contrast, BibA mediates complement evasion in the blood but also appears to mediate cervical cell adhesion (<xref rid="B131" ref-type="bibr">Santi et al., 2007</xref>), although this was not explicitly demonstrated in their murine model of ascending infection. GBS Alps also permit interaction with the cervical epithelium, as their binding to host &#945;<sub>1</sub>&#946;<sub>1</sub> integrins or glycosaminoglycans allows cervical cell invasion <italic toggle="yes">in vitro</italic> (<xref rid="B19" ref-type="bibr">Bolduc et al., 2002</xref>; <xref rid="B10" ref-type="bibr">Baron et al., 2004</xref>; <xref rid="B20" ref-type="bibr">Bolduc and Madoff, 2007</xref>). The ability to invade cervical cells would confer protection from the extracellular host immune response. Although little is known regarding cervical immunity during GBS infection, IL-17-producing neutrophils or CD4<sup>+</sup> T helper cells (Th17) appear to mediate GBS clearance within the murine cervix (<xref rid="B112" ref-type="bibr">Patras et al., 2015</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>, cervix). The roles of other immune cells at this site, including CD8<sup>+</sup> T cells that may mediate clearance of intracellular GBS, remain undefined. As the murine cervix is small, <italic toggle="yes">in vivo</italic> studies of cervical immunity and infection are challenging and may be better suited for human studies or large animal models.</p></sec><sec id="s5_2"><title>The Cervical Mucus Plug: A Barrier to Ascension</title><p>Whether direct interaction with the cervical epithelium is required for ascending infection or not, GBS must pass through the cervix to gain entry to the uterus. During pregnancy, a cervical mucus plug (CMP) is formed in the cervix to separate the lower genital tract from the uterus. The CMP is unique to human pregnancy and is made of viscoelastic material that serves as a physical barrier. However, varied permeability, size, and mucosal adhesion is thought to correlate with risk of uterine infections that may induce PTB (<xref rid="B11" ref-type="bibr">Becher et al., 2009</xref>; <xref rid="B140" ref-type="bibr">Smith-Dupont et al., 2017</xref>; <xref rid="B78" ref-type="bibr">Lacroix et al., 2020</xref>). Such changes may be induced by the dysbiotic vaginal microbiota through the secretion of bacterial vaginosis-associated mucinases (<xref rid="B107" ref-type="bibr">Olmsted et al., 2003</xref>; <xref rid="B66" ref-type="bibr">Hoang et al., 2020</xref>). In addition to serving as a physical barrier, CMPs contain a variety of antimicrobial compounds including cytokines, lactoferrin, lysozyme, and AMPs (<xref rid="B62" ref-type="bibr">Hein et al., 2002</xref>; <xref rid="B83" ref-type="bibr">Lee et al., 2011</xref>; <xref rid="B4" ref-type="bibr">Arko et al., 2012</xref>). Thus, the CMP may be intrinsically antimicrobial and serve as a checkpoint in preventing vaginal pathogens from ascending through the cervix to invade the uterus (<xref rid="B61" ref-type="bibr">Hein et al., 2001</xref>; <xref rid="B11" ref-type="bibr">Becher et al., 2009</xref>). One study interrogating mechanisms of protection using CMPs isolated from pregnant Danish women quantified AMPs and immune mediators present therein and found that native concentrations of AMPs (including cathelicidin, elafin, and lysozyme) in the CMP were insufficient to kill GBS <italic toggle="yes">in vitro</italic> (<xref rid="B161" ref-type="bibr">Vornhagen et al., 2018b</xref>). Despite this inadequacy, cytokines and chemokines from the CMPs could activate immune cells in the blood, thereby enabling the CMP to enhance complement-mediated pathogen killing as observed. Interestingly, CMPs collected from women who received antibiotics exhibited bactericidal effects that were lost upon treatment with penicillinases (<xref rid="B161" ref-type="bibr">Vornhagen et al., 2018b</xref>), suggesting that another protective mechanism of CMPs may be through antibiotic retention. While <italic toggle="yes">ex vivo</italic> studies of CMPs collected from women receiving antibiotics may not accurately reflect the degree of their antimicrobial nature, a combination of antimicrobial products and host factors contained in the CMPs may work in concert to synergistically inhibit bacterial ascension <italic toggle="yes">in vivo</italic>.</p></sec><sec id="s5_3"><title>GBS Hijacks Host Epithelial-Mesenchymal Transition to Facilitate Ascension of Bacteria Into the Uterus</title><p>One host mechanism that can protect against an ascending infection into the uterus is vaginal epithelial exfoliation. This process is facilitated by epithelial-mesenchymal transition (EMT), a highly coordinated loss of epithelial cell tight junctions that leads to the detachment of apical cells, resulting in exfoliation of the epithelium. This phenomenon typically results in efflux of cells harboring pathogenic vaginal bacteria (<xref rid="B133" ref-type="bibr">Schleimer et al., 2007</xref>); however, GBS appears to exploit this response to facilitate ascending infection. During vaginal epithelial cell infection, GBS binds and activates &#945;<sub>1</sub>&#946;<sub>1</sub> integrins, leading to a signaling cascade that displaces &#946;-catenin upon the breakdown of adherens junctions. Once displaced, &#946;-catenin can translocate to the nucleus and activate transcription of multiple genes associated with EMT, including <italic toggle="yes">SNAIL1</italic>, <italic toggle="yes">MYC</italic>, and <italic toggle="yes">AXIN2</italic> (<xref rid="B159" ref-type="bibr">Vornhagen et al., 2018a</xref>). <italic toggle="yes">In vivo</italic>, the expression of these transcripts results in vaginal exfoliation, which typically eradicates other vaginal pathogens. Interestingly, GBS colonization of the murine vaginal tract was unaltered despite EMT-induced vaginal exfoliation, and instead this phenomenon was associated with increased ascending infection (<xref ref-type="fig" rid="f3"><bold>Figure 3</bold></xref>). Administration of recombinant &#945;<sub>1</sub>&#946;<sub>1</sub> integrin to GBS-infected pregnant mice rescued this phenotype, and nearly eliminated subsequent <italic toggle="yes">in utero</italic> transmission to pups and placentas (<xref rid="B159" ref-type="bibr">Vornhagen et al., 2018a</xref>). This strategy appears, thus far, to be unique to GBS and many aspects of this mechanism remain undefined, such as the GBS factor that activates host &#945;<sub>1</sub>&#946;<sub>1</sub> integrin to promote EMT. In addition, it is unclear how EMT impacts vaginal colonization of GBS in humans.</p><fig id="f3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>GBS exploits epithelial-mesenchymal transition (EMT) and vaginal epithelial exfoliation to permit ascending infection. During vaginal infection, GBS binds integrins on the epithelial surface and activates integrin signaling that results in the breakdown of adherens junctions. Displaced &#946;-catenin translocates to the nucleus, activating transcriptional changes of &#946;-catenin targets associated with EMT. Expression of these transcripts <italic toggle="yes">in vivo</italic> leads to vaginal epithelial exfoliation, which facilitates GBS ascension to the uterus and is associated with increased risk for microbial invasion of the amniotic cavity and preterm birth.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcimb-11-720789-g003.jpg"/></fig></sec><sec id="s5_4"><title>GBS Hyaluronidase Impedes Immune Detection and Aids in Ascension to the Uterus</title><p>Hyaluronan (HA) (also called hyaluronic acid) levels increase in the cervix throughout pregnancy, reaching their height during parturition. This glycosaminoglycan plays a structural role in the ECM, and plays additional roles in cell migration, adhesion, and inflammation through its digestion into fragments that interact with a diverse array of host receptors, including toll-like receptor (TLR) 2 and 4 (<xref rid="B46" ref-type="bibr">Dusio et al., 2011</xref>; <xref rid="B41" ref-type="bibr">Dicker et al., 2014</xref>; <xref rid="B89" ref-type="bibr">Mahendroo, 2019</xref>). HA is crucial for maintaining epithelial polarization and barrier function, and loss of HA is associated with ascending infection and subsequent infection-induced PTB (<xref rid="B2" ref-type="bibr">Akgul et al., 2014</xref>). Additionally, low molecular weight HA serves as a damage-associated molecular pattern (DAMP) that initiates TLR2 and 4-mediated inflammation during tissue injury (<xref rid="B154" ref-type="bibr">Termeer et al., 2002</xref>; <xref rid="B151" ref-type="bibr">Taylor et al., 2004</xref>; <xref rid="B132" ref-type="bibr">Scheibner et al., 2006</xref>). GBS exploits this axis through the secretion of hyaluronidase (HylB), which cleaves the pro-inflammatory HA DAMPs into disaccharides, which bind to TLR2/4 and block recognition of GBS ligands. This ultimately results in a dampened immune response (<xref rid="B74" ref-type="bibr">Kolar et al., 2015</xref>). Interestingly, GBS clinical strains isolated from cases of PTB or invasive neonatal infection had high HylB activity, and HylB activity was associated with ascending infection, reduced uterine inflammation, and increased rates of PTB in mice (<xref rid="B160" ref-type="bibr">Vornhagen et al., 2016</xref>). Although these studies partially define interactions in this immune evasion mechanism, the precise timing, immune mediators, and cell types involved remain unidentified.</p></sec><sec id="s5_5"><title>Novel Prophylactics During Ascending Infection</title><p>One prophylactic strategy that might prevent ascending infection is through the inhibition of Alps-mediated cervical cell invasion. This invasion phenotype is mediated by Alps N-termini, which are partially conserved across this protein family. Alps harbor tandem repeats that are immunodominant during natural infection, but the N-terminus is highly immunogenic in the absence of these repeats (<xref rid="B19" ref-type="bibr">Bolduc et al., 2002</xref>; <xref rid="B20" ref-type="bibr">Bolduc and Madoff, 2007</xref>). A peptide derived from the fusion of &#945;C (also called AlpC) and Rib N-termini (hereby called GBS-NN) confers mice with protection against systemic lethal challenge with &#945;C or Rib-expressing strains (<xref rid="T1" ref-type="table"><bold>Table 1</bold></xref>). Antibodies against GBS-NN also inhibit epithelial cell invasion (<xref rid="B143" ref-type="bibr">St&#229;lhammar-Carlemalm et al., 2007</xref>). A vaccine composed of alum-adjuvanted GBS-NN in combination with GBS-NN2, a second fusion peptide derived from N-terminal domains from the other Alps, has been designed (Minervax ApS, Denmark). This vaccine is expected to protect against nearly all GBS clinical isolates since 99% of strains express at least one Alp (<xref rid="B52" ref-type="bibr">Gabrielsen et al., 2017</xref>). The results from a phase I randomized double-blind, placebo-controlled study of healthy, non-pregnant women are promising (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02459262">NCT02459262</ext-link>). Nearly all participants vaccinated with GBS-NN experienced elevated titers, especially when administered as two doses adjuvanted with alum (<xref rid="B50" ref-type="bibr">Fischer et al., 2021</xref>). A follow-up trial similarly tested the dual vaccine, GBS-NN/NN2, in healthy non-pregnant women (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03807245">NCT03807245</ext-link>). This vaccine will also undergo safety and immunogenicity trials in HIV-positive and -negative pregnant women, including up to a six-month follow-up period for the women and their babies following delivery (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04596878">NCT04596878</ext-link>). This vaccine represents a novel strategy through which ascension and cervical persistence may be targeted to ultimately prevent GBS invasive disease.</p><p>Inhibiting the trafficking of GBS from the vagina into the uterus would represent a major accomplishment in preventing fetal infection and the ensuing early-onset neonatal GBS invasive disease. However, in order to inhibit ascension, many large knowledge gaps must be filled. For example, the host factors facilitating GBS trafficking into the uterus are unknown, but may include the host vaginal microbiota, nutritional status, genetics and cervical anatomy. Further, it is exceedingly difficult to identify when GBS enters the uterus in patients, particularly because GBS invasion begins asymptomatically and symptoms only manifest at the time of a fulminant infection. Although murine models for ascending infection exist, their gestational length and fetal development are vastly different compared to humans and, thus, such models are limited in their ability to identify temporal relationships with relevance to human GBS infection. A nonhuman primate with many close similarities to human pregnancy including gestation, fetal development and sensitivity to pathogens is a better suited model of studying ascending infection and for evaluation of therapeutic strategies.</p></sec></sec><sec id="s6"><title>GBS Vertical Transmission</title><sec id="s6_1"><title>Role of the Immune Cells at the Maternal-Fetal Interface in Preventing Vertical Transmission</title><p>The placenta and maternal decidua serves as a multi-layered barrier rich in immune cells that separates maternal and fetal tissues (<xref ref-type="fig" rid="f4"><bold>Figure 4</bold></xref>). The placental disc is composed of a chorionic villous tree that is immersed in maternal blood, where gas and nutrient exchange takes place. Hematogenous pathogens can invade the placenta and gain access to the fetal circulation through the placental chorionic villi. Alternatively, maternal vaginal pathogens can ascend into the uterus through the cervix where they may either encounter the maternal decidua and chorioamniotic membranes or the placenta disc, depending on placental location (which can vary). It is unusual for the placenta to cover the cervix, a condition called placenta previa, so we will consider the most typical scenario where a vaginal pathogen would encounter the maternal decidua and subsequently, the chorioamniotic membranes on its path into the amniotic fluid. Thus, the immune cell rich decidua and chorioamniotic membranes comprise a unique immune environment that can contribute to pathogen clearance or facilitate invasion depending on pathogen virulence and host response.</p><fig id="f4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>Human placental anatomy. This illustration depicts the components of the human placenta (chorionic villous tree), placental chorioamniotic membranes and the associated maternal decidua. GBS must traffic across either the decidua and chorioamniotic membranes or the chorionic villi to infect the fetus. GBS chorioamnionitis and culture-positive amniotic fluid is common in cases of fetal or neonatal invasive disease; thus, it is thought that GBS invasive disease occurs most commonly due to trafficking across the chorioamniotic membranes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcimb-11-720789-g004.jpg"/></fig><p>A variety of immune cells are present in the maternal-fetal interface, and many aspects of their function and protective mechanisms have been studied in the context of GBS infection and chorioamnionitis (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>, placenta/decidua). To study immune responses in the decidua, an <italic toggle="yes">in vitro</italic> approach is to use decidualized immortalized endometrial stromal cells, which mimic this cell type albeit with limitations due to immortalization. Studies using these immortalized decidual cells have determined that GBS stimulation of the mitogen-activated protein kinase (MAPK) pathway leads to NF-&#954;B activation and programmed necroptosis through c-Jun N-terminal kinase (JNK) and p38, respectively (<xref rid="B49" ref-type="bibr">Flaherty et al., 2019</xref>). Using the same decidualized cell line in a co-culture study with the macrophage-like cell line THP-1, another study observed that in response to GBS, decidual stromal cells produce prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) that alters the THP-1-mediated immune response through paracrine signaling. Specifically, PGE<sub>2</sub> enhanced inflammation, but inhibited THP-1 production of TNF-&#945; and reduced phagocytosis of GBS. Conditioned medium from <italic toggle="yes">ex vivo</italic> cultured human placental membranes induced a similar effect on GBS-stimulated THP-1 cells. Mice with GBS chorioamnionitis exhibited macrophage infiltration and increased PGE<sub>2</sub> (<xref rid="B121" ref-type="bibr">Rogers et al., 2018</xref>). Further support for paracrine signaling as a mechanism of placental immune regulation, IL-1 derived from the choriodecidua is needed for amniotic release of human beta defensin-1 during extraplacental membrane infection by GBS (<xref rid="B17" ref-type="bibr">Boldenow et al., 2015</xref>). Thus, host-directed therapies may be effective through direct targeting of cells that contribute to GBS infection, as well as through paracrine signaling that affects bystander cells that modulate immune responses.</p><p>Primary placental cells are perhaps an excellent model to study GBS host-pathogen interactions in the placenta. A study using primary human fetal macrophages isolated from the chorionic villous tree observed that protein kinase D signaling was critical for the GBS-induced production of inflammatory cytokines, NLRP3 inflammasome activation, and activation of NF-&#954;B (<xref rid="B146" ref-type="bibr">Sutton et al., 2019</xref>). This pathway represents another host response that might be targeted therapeutically, although it is important to note that these downstream phenotypes likely contribute to both GBS clearance and immunopathology. A limitation of using primary placental immune cells is that they are unlikely to model conditions that are relevant <italic toggle="yes">in vivo</italic>. For example, when grown in isolation primary macrophages do not receive the immunologic cross-talk from stromal cells to exert paracrine effects. Thus, <italic toggle="yes">ex vivo</italic> analyses of placental immunity should seek to incorporate other cell types and signals encountered <italic toggle="yes">in vivo</italic>. One interesting approach, albeit engineered, is the novel &#8220;fetal membrane on a chip,&#8221; a system that can be easily modified to incorporate stimuli such as GBS, cytokines, hormones, prostaglandins, nutrients, or inhibitors; effluent samples can be collected for downstream analyses including Luminex or mass spectrometry (<xref rid="B8" ref-type="bibr">Aronoff, 2020</xref>). Overall, primary placental cells serve as an interesting model of host-pathogen interactions, but benefit from the addition of paracrine effects and novel approaches to model the anatomical complexity of the placenta.</p><p>Although <italic toggle="yes">in vitro</italic> technologies are improving, the best way to study immune responses is in a host. Thus, animal models of pregnancy-associated GBS infection and GBS chorioamnionitis are essential to inform placental immunity. In a murine model of GBS vaginal inoculation during pregnancy, neutrophil infiltrates were observed in the choriodecidua and placenta; further, these neutrophils produced neutrophil extracellular traps (NETs) that immobilized GBS and repressed GBS growth <italic toggle="yes">via</italic> lactoferrin-mediated iron sequestration (<xref rid="B75" ref-type="bibr">Kothary et al., 2017</xref>). Another group noted NET production in non-pregnant mice inoculated vaginally with GBS, which was dependent on GBS hemolysin (<xref rid="B29" ref-type="bibr">Carey et al., 2014</xref>), suggesting that GBS virulence factors may mediate this neutrophil response. However, hyperhemolytic GBS can evade NETs <italic toggle="yes">via</italic> direct neutrophil killing (<xref rid="B18" ref-type="bibr">Boldenow et al., 2016</xref>). Interestingly, production of extracellular traps is not a mechanism unique to neutrophils; primary placental macrophages release similar macrophage extracellular traps (METs) during GBS infection <italic toggle="yes">ex vivo</italic>. METs were produced in an ROS-dependent manner, contained a variety of matrix metalloproteases and were observed in the fetal chorioamniotic membranes (<xref rid="B45" ref-type="bibr">Doster et al., 2018</xref>). The production of these extracellular traps may adversely affect pregnancy outcome, as the production of matrix metalloproteases and neutrophil elastase can stimulate uterine contractions and are associated with chorioamnionitis and PTB (<xref rid="B144" ref-type="bibr">Sundrani et al., 2012</xref>; <xref rid="B150" ref-type="bibr">Tambor et al., 2013</xref>; <xref rid="B163" ref-type="bibr">Walsh et al., 2018</xref>). Animal models of GBS infection in pregnancy are key for elucidating complex host-pathogen responses that begin with vaginal inoculation and result in invasion of the amniotic cavity and fetus.</p></sec><sec id="s6_2"><title>GBS Trafficking Into the Amniotic Cavity</title><p>After crossing the maternal decidua and chorioamniotic membranes, GBS must traffic into the amniotic fluid and adapt to a new niche in order to subsequently infect the fetus. When GBS was grown in amniotic fluid, transcriptional changes altering metabolism of amino acids and carbohydrates was observed, which is likely related to the nutritional requirements of GBS in amniotic fluid. Further, growth in amniotic fluid also resulted in differentially expression in virulence-associated genes. Adhesins were downregulated, whereas, capsule, hemolysin, and IL-8 proteinase were upregulated, suggesting that GBS modulates its virulence factors in response to amniotic fluid (<xref rid="B139" ref-type="bibr">Sitkiewicz et al., 2009</xref>). Expression of the <italic toggle="yes">fru2</italic> metabolic operon which encodes factors involved in fructose metabolism (<xref rid="B114" ref-type="bibr">Patron et al., 2017</xref>) was induced, suggesting that this carbon source might be important for GBS survival in this niche. Although these studies highlight adaptations that GBS might undergo following microbial invasion of the amniotic cavity, the relevance of these findings <italic toggle="yes">in vivo</italic> are unclear. Recently, a transposon screen identified a novel GBS transcription factor, MrvR, that was important for survival in amniotic fluid. MrvR; deletion of <italic toggle="yes">mrvR</italic> reduced GBS survival in amniotic fluid and impaired biofilm formation. Pregnant mice vaginally-infected by MrvR-null GBS exhibited normal vaginal persistence and consistent ascending infection, but these mice did not experience PTB (<xref rid="B36" ref-type="bibr">Dammann et al., 2021</xref>), suggesting that MrvR may mainly promote bacterial survival <italic toggle="yes">in vivo</italic>.</p><p>Once GBS has invaded the amniotic cavity, immune recognition and inflammatory mediators contribute to the development of adverse pregnancy outcomes. In a nonhuman primate model, inoculation of GBS into the amniotic fluid increased amniotic fluid IL-1&#946;, TNF-&#945;, IL-6, and IL-8 cytokine/chemokine levels (<xref rid="B58" ref-type="bibr">Gravett et al., 1994</xref>). When these individual cytokines were inoculated into the amniotic fluid of a rhesus macaque model to interrogate the effects of each individual cytokine, only the nonhuman primates inoculated with IL-1&#946; or TNF-&#945; developed preterm labor (<xref rid="B126" ref-type="bibr">Sadowsky et al., 2006</xref>). These observations suggest that certain inflammatory cytokines are sufficient to induce preterm labor and PTB. Prostaglandins, which increase cervical softening, are also observed to increase in the amniotic fluid during GBS invasion of the chorioamniotic membranes and amniotic cavity (<xref rid="B18" ref-type="bibr">Boldenow et al., 2016</xref>; <xref rid="B32" ref-type="bibr">Coleman et al., 2021</xref>). A recent study found that higher amniotic fluid IL-6 and IL-8 concentrations are also useful predictors of fetal lung injury in a nonhuman primate model of GBS chorioamnionitis (<xref rid="B94" ref-type="bibr">McCartney et al., 2021</xref>). Thus, amniotic fluid cytokines and chemokines play a role in the development of adverse maternal and fetal outcomes during GBS infection.</p><p>Finally, recent studies have begun to evaluate the roles of immune cells in the amniotic fluid on bacterial clearance. Human amniotic fluid neutrophils actively phagocytose GBS <italic toggle="yes">ex vivo</italic> in a manner similar to what has been observed by neutrophils in the blood (<xref rid="B57" ref-type="bibr">Gomez-Lopez et al., 2017</xref>). This represents one mechanism that may contribute to reduction of GBS burden in the amniotic cavity, although this has not been established <italic toggle="yes">in vivo</italic>. Other phagocytes such as macrophages may also mediate amniotic fluid clearance, although this has not been examined. Further, immune cell subsets that contribute to pro-inflammatory cytokine responses associated with adverse outcomes remain undefined.</p></sec><sec id="s6_3"><title>GBS Virulence Factors Modulate Crucial Balance Between Chorioamnionitis and Microbial Invasion of the Amniotic Cavity</title><p>GBS can modulate host immune responses at the maternal-fetal interface to promote chorioamnionitis and microbial invasion of the amniotic cavity. An important virulence factor GBS employs to gain access to the amniotic cavity through invasion of the chorioamniotic membranes is hemolysin. In fact, GBS clinical strains isolated from the chorioamniotic membranes or amniotic fluid of women in preterm labor from a small case series exhibited a hyperhemolytic phenotype. GBS hemolysin induces the release of proinflammatory cytokines, such as IL-6, IL-8, IL-1&#946;, and TNF-&#945; in chorioamniotic membranes, culminating in barrier disruption (<xref rid="B167" ref-type="bibr">Whidbey et al., 2013</xref>). The cytotoxic activity of hemolysin is driven through intercalation of the toxin within the plasma membrane, leading to bilayer disruption followed by rapid efflux of potassium ions. In human macrophages, hemolysin-mediated potassium ion efflux triggers NLRP3 inflammasome formation and activates caspase 1 signaling, ultimately causing cell death by pyroptosis (<xref rid="B168" ref-type="bibr">Whidbey et al., 2015</xref>). Although caspase 1 activation can promote GBS clearance (<xref rid="B35" ref-type="bibr">Costa et al., 2012</xref>), the induction of robust inflammatory responses is likely detrimental during pregnancy, as the host must balance inflammation during infection to protect the mother and immunoregulatory responses to prevent preterm labor (<xref rid="B168" ref-type="bibr">Whidbey et al., 2015</xref>). Notably, in a pregnant murine model, hyperhemolytic GBS promoted preterm labor and significantly increased the rate of fetal death compared to an isogenic nonhemolytic strain. Intriguingly, NLRP3 inflammasome activation exacerbated GBS-mediated fetal injury. However, other host factors may also contribute to these pregnancy complications, as fetal death was still observed in NLRP3-deficient mice, albeit at lower levels than wildtype mice (<xref rid="B168" ref-type="bibr">Whidbey et al., 2015</xref>). In pregnant nonhuman primates that were choriodecidually infected with hyperhemolytic COH1&#916;<italic toggle="yes">covR</italic>, GBS trafficked across the chorioamniotic membranes to invade the amniotic fluid and fetus more frequently than with a non-hemolytic GBS strain (COH1&#916;<italic toggle="yes">covR</italic>&#916;<italic toggle="yes">cylE</italic>) (<xref rid="B18" ref-type="bibr">Boldenow et al., 2016</xref>). Microbial invasion of the amniotic cavity was associated with robust neutrophilic infiltration of the chorioamniotic membranes and production of neutrophil extracellular traps and proinflammatory cytokines. The hyperhemolytic GBS strain subverted all of these host innate immune responses to infect the amniotic fluid and ultimately lead to adverse outcomes including fetal sepsis and PTB (<xref rid="B18" ref-type="bibr">Boldenow et al., 2016</xref>).</p><p>In contrast to the robust proinflammatory response to hemolysin, GBS can also dampen immune responses at the maternal-fetal interface through the action of HylB, which interferes with TLR2/4-mediated immune signaling (<xref rid="B74" ref-type="bibr">Kolar et al., 2015</xref>). Similar to COH1&#916;<italic toggle="yes">covR</italic>-infected animals, pregnant nonhuman primates choriodecidually infected with GB37, a GBS strain with high HylB activity, consistently experienced preterm labor, microbial invasion of the amniotic cavity and fetal sepsis (<xref rid="B32" ref-type="bibr">Coleman et al., 2021</xref>). In these experiments, neutrophils also infiltrated the chorioamniotic membranes, but were not successful in containing the infection and preventing microbial invasion of the amniotic cavity. <italic toggle="yes">Ex vivo</italic> experiments using paired maternal and neonatal cord blood indicate that HylB-mediated TLR2/4 dampening resulting in reduced production of antimicrobial reactive oxygen species (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>, maternal/cord blood) (<xref rid="B32" ref-type="bibr">Coleman et al., 2021</xref>). Finally, digital spatial profiling of GBS-infected choriomaniotic membranes highlighted HylB-specific dampening of inflammatory responses (<xref rid="B32" ref-type="bibr">Coleman et al., 2021</xref>). This blunting of innate immune responses observed in GB37-infected animals is directly in contrast to the rapid proinflammatory response observed with the hyperhemolytic GBS (<xref rid="B18" ref-type="bibr">Boldenow et al., 2016</xref>). These studies highlight key virulence factor-mediated differences between two GBS strains that induce similar adverse outcomes in pregnant nonhuman primates, and emphasizes the diverse nature of GBS virulence factors.</p></sec><sec id="s6_4"><title>Placental Chorioamniotic Weakening After GBS Infection</title><p>GBS infection and inflammation of the amniotic fluid can contribute to preterm premature rupture of membranes (pPROM) through weakening of the placental chorioamniotic membranes, ultimately inducing PTB. Multiple factors contribute to membrane weakening, including matrix metalloproteinases, apoptosis, oxidative stress, and other neutrophil proteases (<xref rid="B81" ref-type="bibr">Lannon et al., 2014</xref>; <xref rid="B122" ref-type="bibr">Romero et al., 2014</xref>). An important mechanism contributing to pPROM was demonstrated using a nonhuman primate model of GBS is EMT (<xref rid="B165" ref-type="bibr">Weed et al., 2020</xref>). EMT is a coordinated process whereby epithelial cells change morphology, retract their cytoskeleton, lose cell-cell adhesions and become motile; overall, this process reduces tissue integrity. In a nonhuman primate model, a choriodecidual inoculation of GBS was associated with transcriptional responses in the chorioamniotic membranes characterized by downregulation of cytostructural genes and microRNA gene expression (i.e. miR-200b, miR-203-5p) consistent with EMT (<xref rid="B157" ref-type="bibr">Vanderhoeven et al., 2014</xref>). Immunohistochemistry of the chorioamniotic membranes also demonstrated partial loss of surface E-cadherin, increased N-cadherin expression, and vimentin staining near areas of neutrophil influx, all signs of reduced amniotic epithelial integrity (<xref rid="B165" ref-type="bibr">Weed et al., 2020</xref>). Thus, in addition to the role of EMT in vaginal exfoliation, EMT may also impair chorioamniotic membrane tissue integrity and predispose GBS-infected pregnant women to pPROM.</p></sec></sec><sec id="s7"><title>Conclusion</title><p>In summary, GBS inflicts an annual public health burden on pregnant women and neonates, which is disproportionately concentrated in low-income countries. National and region-specific discrepancies between screening guidelines and the use of IAP confounds the accurate detection of invasive GBS disease cases, limiting the ability to control the associated adverse outcomes through intervention. Although a combination of a global universal screening approach and IAP use would result in the greatest reduction in maternal, fetal, and neonatal adverse outcomes, this is not realistic for many low-income countries that lack resources to implement these approaches; further, some higher income countries have a low prevalence of invasive GBS disease, leading them to instead adopt a more cost-effective risk-based approach to treating GBS in pregnancy. The solution to reducing invasive GBS disease in pregnant women and neonates is not simple, but the development of a GBS vaccine would be a major step forward in preventing disease.</p><p>This review highlights recent discoveries that elucidate the interplay between GBS and the host, defining the mechanisms that GBS employs to successfully disseminate to vulnerable host niches during pregnancy. In recent years, major strides have been made to improve our understanding of GBS vaginal colonization, ascending infection, and congenital infection, ultimately facilitating the strategic development of several candidate vaccines with demonstrated efficacy in animal models or human clinical trials. Although it is too early to forecast whether these vaccines will someday receive FDA-approval, their success symbolizes a major step towards reducing the global burden of GBS invasive disease.</p></sec><sec id="s8"><title>Author Contributions</title><p>All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="funding-information" id="s9"><title>Funding</title><p>This work was supported by funding from the National Institutes of Health grants R01AI133976, R01AI145890, R01HD098713 to LR and KW, R01AI152268 to LR., T32AI055396 to AF (PI: Fang), T32AI007509 to AB (PI: Campbell), and seed funds from Seattle Children&#8217;s Research Institute to L.R. This work was also supported by the P51OD010425, which is the core grant of the Washington National Primate Research Center. Additional support came from a U42OD011123, which funds the breeding colony at the Washington National Primate Research Center.</p></sec><sec sec-type="COI-statement" id="s10"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s11"><title>Publisher&#8217;s Note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors acknowledge Jessie Brown for graphic design. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://BioRender.com">BioRender.com</uri> was used to create most elements of <xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Absalon</surname><given-names>J.</given-names></name><name name-style="western"><surname>Segall</surname><given-names>N.</given-names></name><name name-style="western"><surname>Block</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Center</surname><given-names>K. J.</given-names></name><name name-style="western"><surname>Scully</surname><given-names>I. L.</given-names></name><name name-style="western"><surname>Giardina</surname><given-names>P. C.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Safety and Immunogenicity of a Novel Hexavalent Group B Streptococcus Conjugate Vaccine in Healthy, Non-Pregnant Adults: A Phase 1/2, Randomised, Placebo-Controlled, Observer-Blinded, Dose-Escalation Trial</article-title>. <source>Lancet Infect. Dis.</source><volume>21</volume>, <fpage>263</fpage>&#8211;<lpage>274</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/S1473-3099(20)30478-3</pub-id><pub-id pub-id-type="pmid">32891191</pub-id><pub-id pub-id-type="pmcid">PMC9760110</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akgul</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Word</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>Ensign</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lydon</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hanes</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Hyaluronan in Cervical Epithelia Protects Against Infection-Mediated Preterm Birth</article-title>. <source>J. Clin. Invest.</source><volume>124</volume>, <fpage>5481</fpage>&#8211;<lpage>5489</lpage>. &#160;<pub-id pub-id-type="doi">10.1172/JCI78765</pub-id><pub-id pub-id-type="pmid">25384213</pub-id><pub-id pub-id-type="pmcid">PMC4348952</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altoparlak</surname><given-names>U.</given-names></name><name name-style="western"><surname>Kadanali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kadanali</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Genital Flora in Pregnancy and Its Association With Group B Streptococcal Colonization</article-title>. <source>Int. J. Gynecol. Obstet.</source><volume>87</volume>, <fpage>245</fpage>&#8211;<lpage>246</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ijgo.2004.08.006</pub-id><pub-id pub-id-type="pmid">15548398</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arko</surname><given-names>D.</given-names></name><name name-style="western"><surname>Dovnik</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fokter</surname><given-names>N.</given-names></name><name name-style="western"><surname>Taka&#269;</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>The Role of Genital Pathogens in Morbidity Following Diathermy Loop Excision of the Transformation Zone of the Uterine Cervix</article-title>. <source>Int. J. Gynecol. Obstet.</source><volume>117</volume>, <fpage>27</fpage>&#8211;<lpage>29</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ijgo.2011.11.015</pub-id><pub-id pub-id-type="pmid">22265189</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armistead</surname><given-names>B.</given-names></name><name name-style="western"><surname>Herrero-Foncubierta</surname><given-names>P.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Quach</surname><given-names>P.</given-names></name><name name-style="western"><surname>Whidbey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Justicia</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2020</year>a). <article-title>Lipid Analogs Reveal Features Critical for Hemolysis and Diminish Granadaene Mediated Group B Streptococcus Infection</article-title>. <source>Nat. Commun.</source><volume>11</volume> (<issue>1</issue>), <fpage>502</fpage>. &#160;<pub-id pub-id-type="doi">10.1038/s41467-020-15282-0</pub-id><pub-id pub-id-type="pmid">32198389</pub-id><pub-id pub-id-type="pmcid">PMC7083881</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armistead</surname><given-names>B.</given-names></name><name name-style="western"><surname>Quach</surname><given-names>P.</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Santana-Ufret</surname><given-names>V.</given-names></name><name name-style="western"><surname>Furuta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Brokaw</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2020</year>b). <article-title>Hemolytic Membrane Vesicles of Group B Streptococcus Promote Infection</article-title>. <source>J. Infect. Dis.</source><volume>223</volume> (<issue>8</issue>), <fpage>1488</fpage>&#8211;<lpage>1496</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/infdis/jiaa548</pub-id><pub-id pub-id-type="pmcid">PMC8064051</pub-id><pub-id pub-id-type="pmid">32861213</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armistead</surname><given-names>B.</given-names></name><name name-style="western"><surname>Whidbey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Herrero-Foncubierta</surname><given-names>P.</given-names></name><name name-style="western"><surname>Quach</surname><given-names>P.</given-names></name><name name-style="western"><surname>Haidour</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>The Cyl Genes Reveal the Biosynthetic and Evolutionary Origins of the Group B Streptococcus Hemolytic Lipid, Granadaene</article-title>. <source>Front. Microbiol.</source><volume>10</volume>, <elocation-id>3123</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fmicb.2019.03123</pub-id><pub-id pub-id-type="pmid">32038561</pub-id><pub-id pub-id-type="pmcid">PMC6985545</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aronoff</surname><given-names>D. M.</given-names></name></person-group> (<year>2020</year>). <article-title>Deconstructing Extraplacental Membranes to Understand Bacterial Chorioamnionitis</article-title>. <source>Trans. Am. Clin. Climatol. Assoc.</source><volume>131</volume>, <fpage>72</fpage>&#8211;<lpage>79</lpage>.
<pub-id pub-id-type="pmid">32675845</pub-id><pub-id pub-id-type="pmcid">PMC7358510</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>E. L.</given-names></name><name name-style="western"><surname>Byland</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Bonakdar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Randis</surname><given-names>T. M.</given-names></name><name name-style="western"><surname>Ratner</surname><given-names>A. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Mucosal Vaccination Promotes Clearance of Streptococcus Agalactiae Vaginal Colonization</article-title>. <source>Vaccine</source><volume>35</volume>, <fpage>1273</fpage>&#8211;<lpage>1280</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.vaccine.2017.01.029</pub-id><pub-id pub-id-type="pmid">28162823</pub-id><pub-id pub-id-type="pmcid">PMC5319564</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baron</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Bolduc</surname><given-names>G. R.</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>M. B.</given-names></name><name name-style="western"><surname>Aup&#233;rin</surname><given-names>T. C.</given-names></name><name name-style="western"><surname>Madoff</surname><given-names>L. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Alpha C Protein of Group B Streptococcus Binds Host Cell Surface Glycosaminoglycan and Enters Cells by an Actin-Dependent Mechanism</article-title>. <source>J.&#160;Biol. Chem.</source><volume>279</volume>, <fpage>24714</fpage>&#8211;<lpage>24723</lpage>. &#160;<pub-id pub-id-type="doi">10.1074/jbc.M402164200</pub-id><pub-id pub-id-type="pmid">15044471</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becher</surname><given-names>N.</given-names></name><name name-style="western"><surname>Waldorf</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>Hein</surname><given-names>M.</given-names></name><name name-style="western"><surname>Uldbjerg</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>The Cervical Mucus Plug: Structured Review of the Literature</article-title>. <source>Acta Obstet. Gynecol. Scand.</source><volume>88</volume>, <fpage>502</fpage>&#8211;<lpage>513</lpage>. &#160;<pub-id pub-id-type="doi">10.1080/00016340902852898</pub-id><pub-id pub-id-type="pmid">19330570</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bellais</surname><given-names>S.</given-names></name><name name-style="western"><surname>Six</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fouet</surname><given-names>A.</given-names></name><name name-style="western"><surname>Longo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dmytruk</surname><given-names>N.</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Capsular Switching in Group B Streptococcus CC17 Hypervirulent Clone: A Future Challenge for Polysaccharide Vaccine Development</article-title>. <source>J. Infect. Dis.</source><volume>206</volume>, <fpage>1745</fpage>&#8211;<lpage>1752</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/infdis/jis605</pub-id><pub-id pub-id-type="pmid">23002446</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bianchi-Jassir</surname><given-names>F.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>P.</given-names></name><name name-style="western"><surname>To</surname><given-names>K. N.</given-names></name><name name-style="western"><surname>Carreras-Abad</surname><given-names>C.</given-names></name><name name-style="western"><surname>Seale</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Jauneikaite</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Systematic Review of Group B Streptococcal Capsular Types, Sequence Types and Surface Proteins as Potential Vaccine Candidates</article-title>. <source>Vaccine</source><volume>38</volume>, <fpage>6682</fpage>&#8211;<lpage>6694</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.vaccine.2020.08.052</pub-id><pub-id pub-id-type="pmid">32888741</pub-id><pub-id pub-id-type="pmcid">PMC7526974</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bianchi-Jassir</surname><given-names>F.</given-names></name><name name-style="western"><surname>Seale</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Kohli-Lynch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lawn</surname><given-names>J. E.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-Analyses</article-title>. <source>Clin. Infect. Dis.</source><volume>65</volume>, <fpage>S133</fpage>&#8211;<lpage>S142</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/cid/cix661</pub-id><pub-id pub-id-type="pmid">29117329</pub-id><pub-id pub-id-type="pmcid">PMC5850429</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bisharat</surname><given-names>N.</given-names></name><name name-style="western"><surname>Crook</surname><given-names>D. W.</given-names></name><name name-style="western"><surname>Leigh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Harding</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Ward</surname><given-names>P. N.</given-names></name><name name-style="western"><surname>Coffey</surname><given-names>T. J.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Hyperinvasive Neonatal Group B Streptococcus Has Arisen From a Bovine Ancestor</article-title>. <source>J. Clin. Microbiol.</source><volume>42</volume>, <fpage>2161</fpage>&#8211;<lpage>2167</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/JCM.42.5.2161-2167.2004</pub-id><pub-id pub-id-type="pmid">15131184</pub-id><pub-id pub-id-type="pmcid">PMC404684</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bodaszewska</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brzychczy-W&#322;och</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gosiewski</surname><given-names>T.</given-names></name><name name-style="western"><surname>Adamski</surname><given-names>P.</given-names></name><name name-style="western"><surname>Strus</surname><given-names>M.</given-names></name><name name-style="western"><surname>Heczko</surname><given-names>P. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Evaluation of Group B Streptococcus Susceptibility to Lactic Acid Bacteria Strains</article-title>. <source>Med. Dosw. Mikrobiol.</source><volume>62</volume>, <fpage>153</fpage>&#8211;<lpage>161</lpage>.
<pub-id pub-id-type="pmid">20873488</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boldenow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>Chames</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Aronoff</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Xi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Loch-Caruso</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Role of Cytokine Signaling in Group B Streptococcus-Stimulated Expression of Human Beta Defensin-2 in Human Extraplacental Membranes</article-title>. <source>Am. J. Reprod. Immunol.</source><volume>73</volume>, <fpage>263</fpage>&#8211;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1111/aji.12325</pub-id><pub-id pub-id-type="pmid">25263616</pub-id><pub-id pub-id-type="pmcid">PMC4323989</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boldenow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gendrin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bierle</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vornhagen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Group B Streptococcus Circumvents Neutrophils and Neutrophil Extracellular Traps During Amniotic Cavity Invasion and Preterm Labor</article-title>. <source>Sci. Immunol.</source><volume>1</volume> (<issue>4</issue>), <elocation-id>eaah4576</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1126/sciimmunol.aah4576</pub-id><pub-id pub-id-type="pmid">27819066</pub-id><pub-id pub-id-type="pmcid">PMC5089172</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolduc</surname><given-names>G. R.</given-names></name><name name-style="western"><surname>Baron</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Gravekamp</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lachenauer</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>Madoff</surname><given-names>L. C.</given-names></name></person-group> (<year>2002</year>). <article-title>The Alpha C Protein Mediates Internalization of Group B Streptococcus Within Human Cervical Epithelial Cells</article-title>. <source>Cell. Microbiol.</source><volume>4</volume>, <fpage>751</fpage>&#8211;<lpage>758</lpage>. &#160;<pub-id pub-id-type="doi">10.1046/j.1462-5822.2002.00227.x</pub-id><pub-id pub-id-type="pmid">12427097</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolduc</surname><given-names>G. R.</given-names></name><name name-style="western"><surname>Madoff</surname><given-names>L. C.</given-names></name></person-group> (<year>2007</year>). <article-title>The Group B Streptococcal Alpha C Protein Binds &#945;1&#946;1-Integrin Through a Novel KTD Motif That Promotes Internalization of GBS Within Human Epithelial Cells</article-title>. <source>Microbiology</source><volume>153</volume>, <fpage>4039</fpage>&#8211;<lpage>4049</lpage>. &#160;<pub-id pub-id-type="doi">10.1099/mic.0.2007/009134-0</pub-id><pub-id pub-id-type="pmid">18048918</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boskey</surname><given-names>E. R.</given-names></name><name name-style="western"><surname>Cone</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>Whaley</surname><given-names>K. J.</given-names></name><name name-style="western"><surname>Moench</surname><given-names>T. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Origins of Vaginal Acidity: High D/L Lactate Ratio Is Consistent With Bacteria Being the Primary Source</article-title>. <source>Hum. Reprod.</source><volume>16</volume>, <fpage>1809</fpage>&#8211;<lpage>1813</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/humrep/16.9.1809</pub-id><pub-id pub-id-type="pmid">11527880</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brotman</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Shardell</surname><given-names>M. D.</given-names></name><name name-style="western"><surname>Gajer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fadrosh</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Silver</surname><given-names>M. I.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Association Between the Vaginal Microbiota, Menopause Status, and Signs of Vulvovaginal Atrophy</article-title>. <source>Menopause</source><volume>25</volume>, <fpage>1321</fpage>&#8211;<lpage>1330</lpage>. &#160;<pub-id pub-id-type="doi">10.1097/gme.0b013e3182a4690b</pub-id><pub-id pub-id-type="pmid">30358729</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brzychczy-Wloch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pabian</surname><given-names>W.</given-names></name><name name-style="western"><surname>Majewska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zuk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kielbik</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gosiewski</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Dynamics of Colonization With Group B Streptococci in Relation to Normal Flora in Women During Subsequent Trimesters of Pregnancy</article-title>. <source>New Microbiol.</source><volume>37</volume>, <fpage>307</fpage>&#8211;<lpage>319</lpage>.
<pub-id pub-id-type="pmid">25180845</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buscetta</surname><given-names>M.</given-names></name><name name-style="western"><surname>Papasergi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Firon</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pietrocola</surname><given-names>G.</given-names></name><name name-style="western"><surname>Biondo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mancuso</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>FbsC, A Novel Fibrinogen-Binding Protein, Promotes Streptococcus Agalactiae-Host Cell Interactions</article-title>. <source>J. Biol. Chem.</source><volume>289</volume>, <fpage>21003</fpage>&#8211;<lpage>21015</lpage>. &#160;<pub-id pub-id-type="doi">10.1074/jbc.M114.553073</pub-id><pub-id pub-id-type="pmid">24904056</pub-id><pub-id pub-id-type="pmcid">PMC4110306</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buurman</surname><given-names>E. T.</given-names></name><name name-style="western"><surname>Timofeyeva</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Kodali</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization</article-title>. <source>J. Infect. Dis.</source><volume>220</volume>, <fpage>105</fpage>&#8211;<lpage>115</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/infdis/jiz062</pub-id><pub-id pub-id-type="pmid">30778554</pub-id><pub-id pub-id-type="pmcid">PMC6548902</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campisi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rosini</surname><given-names>R.</given-names></name><name name-style="western"><surname>Romano</surname><given-names>M. R.</given-names></name><name name-style="western"><surname>Balducci</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>V.</given-names></name><name name-style="western"><surname>Brogioni</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Group B Streptococcus Chimeric Capsular Polysaccharides as Novel Multivalent Vaccine Candidates</article-title>. <source>Glycoconj. J.</source><volume>38</volume> (<issue>4</issue>), <fpage>447</fpage>&#8211;<lpage>457</lpage>. &#160;<pub-id pub-id-type="doi">10.1007/s10719-021-10000-4</pub-id><pub-id pub-id-type="pmid">33956253</pub-id><pub-id pub-id-type="pmcid">PMC8100357</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carboni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Adamo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fabbrini</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Ricco</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cattaneo</surname><given-names>V.</given-names></name><name name-style="western"><surname>Brogioni</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Structure of a Protective Epitope of Group B Streptococcus Type III Capsular Polysaccharide</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>114</volume>, <fpage>5017</fpage>&#8211;<lpage>5022</lpage>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1701885114</pub-id><pub-id pub-id-type="pmid">28439022</pub-id><pub-id pub-id-type="pmcid">PMC5441712</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carboni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Angiolini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Fabbrini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brogioni</surname><given-names>B.</given-names></name><name name-style="western"><surname>Corrado</surname><given-names>A.</given-names></name><name name-style="western"><surname>Berti</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Evaluation of Immune Responses to Group B Streptococcus Type III Oligosaccharides Containing a Minimal Protective Epitope</article-title>. <source>J. Infect. Dis.</source><volume>221</volume>, <fpage>943</fpage>&#8211;<lpage>947</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/infdis/jiz551</pub-id><pub-id pub-id-type="pmid">31641758</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carey</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>C. K.</given-names></name><name name-style="western"><surname>Mirza</surname><given-names>S.</given-names></name><name name-style="western"><surname>Irving-Rodgers</surname><given-names>H.</given-names></name><name name-style="western"><surname>Webb</surname><given-names>R. I.</given-names></name><name name-style="western"><surname>Lam</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Infection and Cellular Defense Dynamics in a Novel 17&#946;-Estradiol Murine Model of Chronic Human Group B Streptococcus Genital Tract Colonization Reveal a Role for Hemolysin in Persistence and Neutrophil Accumulation</article-title>. <source>J. Immunol.</source><volume>192</volume>, <fpage>1718</fpage>&#8211;<lpage>1731</lpage>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.1202811</pub-id><pub-id pub-id-type="pmid">24453257</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S. L.</given-names></name></person-group> (<year>2019</year>). <article-title>Genomic Insights Into the Distribution and Evolution of Group B Streptococcus</article-title>. <source>Front. Microbiol.</source><volume>10</volume>, <elocation-id>1447</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fmicb.2019.01447</pub-id><pub-id pub-id-type="pmid">31316488</pub-id><pub-id pub-id-type="pmcid">PMC6611187</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiarot</surname><given-names>E.</given-names></name><name name-style="western"><surname>Spagnuolo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Maccari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Naimo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Acquaviva</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cecchi</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Protective Effect of Group B Streptococcus Type-III Polysaccharide Conjugates Against Maternal Colonization, Ascending Infection and Neonatal Transmission in Rodent Models</article-title>. <source>Sci. Rep.</source><volume>8</volume> (<issue>1</issue>), <fpage>2593</fpage>. &#160;<pub-id pub-id-type="doi">10.1038/s41598-018-20609-5</pub-id><pub-id pub-id-type="pmid">29416049</pub-id><pub-id pub-id-type="pmcid">PMC5803199</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coleman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Armistead</surname><given-names>B.</given-names></name><name name-style="western"><surname>Orvis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Quach</surname><given-names>P.</given-names></name><name name-style="western"><surname>Brokaw</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gendrin</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Hyaluronidase Impairs Neutrophil Function and Promotes Group B Streptococcus Invasion and Preterm Labor in Nonhuman Primates</article-title>. <source>MBio</source><volume>12</volume>, <fpage>1</fpage>&#8211;<lpage>18</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/mBio.03115-20</pub-id><pub-id pub-id-type="pmcid">PMC8545101</pub-id><pub-id pub-id-type="pmid">33402537</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cook</surname><given-names>L. C. C.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Maienschein-Cline</surname><given-names>M.</given-names></name><name name-style="western"><surname>Federle</surname><given-names>M. J.</given-names></name></person-group> (<year>2018</year>). <article-title>A Vaginal Tract Signal Detected by the Group B Streptococcus Saers System Elicits Transcriptomic Changes and Enhances Murine Colonization</article-title>. <source>Infect. Immun.</source><volume>86</volume> (<issue>4</issue>), <page-range>e00762&#8211;17</page-range>. &#160;<pub-id pub-id-type="doi">10.1128/IAI.00762-17</pub-id><pub-id pub-id-type="pmcid">PMC5865029</pub-id><pub-id pub-id-type="pmid">29378799</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cools</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jespers</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>L.</given-names></name><name name-style="western"><surname>Crucitti</surname><given-names>T.</given-names></name><name name-style="western"><surname>Delany-Moretlwe</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mwaura</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>A Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia Coli in Resource-Poor Settings: Prevalences and Risk Factors</article-title>. <source>PloS One</source><volume>11</volume> (<issue>1</issue>), <elocation-id>e0148052</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0148052</pub-id><pub-id pub-id-type="pmid">26811897</pub-id><pub-id pub-id-type="pmcid">PMC4727807</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name><name name-style="western"><surname>Signorino</surname><given-names>G.</given-names></name><name name-style="western"><surname>Malara</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cardile</surname><given-names>F.</given-names></name><name name-style="western"><surname>Biondo</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Activation of the NLRP3 Inflammasome by Group B Streptococci</article-title>. <source>J. Immunol.</source><volume>188</volume>, <fpage>1953</fpage>&#8211;<lpage>1960</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1102543</pub-id><pub-id pub-id-type="pmid">22250086</pub-id><pub-id pub-id-type="pmcid">PMC3273589</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dammann</surname><given-names>A. N.</given-names></name><name name-style="western"><surname>Chamby</surname><given-names>A. B.</given-names></name><name name-style="western"><surname>Catomeris</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Tettelin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Pijkeren</surname><given-names>J. P. V.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Genome-Wide Fitness Analysis of Group B Streptococcus in Human Amniotic Fluid Reveals a Transcription Factor That Controls Multiple Virulence Traits</article-title>. <source>PloS Pathog.</source><volume>17</volume> (<issue>3</issue>), <elocation-id>e1009116</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1371/journal.ppat.1009116</pub-id><pub-id pub-id-type="pmid">33684178</pub-id><pub-id pub-id-type="pmcid">PMC7971860</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniel Johannes R&#246;nnqvist</surname><given-names>P.</given-names></name><name name-style="western"><surname>Birgitta Forsgren-Brusk</surname><given-names>U.</given-names></name><name name-style="western"><surname>Elisabeth Grahn-H&#229;kansson</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Lactobacilli in the Female Genital Tract in Relation to Other Genital Microbes and Vaginal pH</article-title>. <source>Acta Obstet. Gynecol. Scand.</source><volume>85</volume>, <fpage>726</fpage>&#8211;<lpage>735</lpage>. &#160;<pub-id pub-id-type="doi">10.1080/00016340600578357</pub-id><pub-id pub-id-type="pmid">16752267</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Gregorio</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>Ju&#225;rez Tom&#225;s</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Leccese Terraf</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Nader-Mac&#237;as</surname><given-names>M. E. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Preventive Effect of Lactobacillus Reuteri CRL1324 on Group B Streptococcus Vaginal Colonization in an Experimental Mouse Model</article-title>. <source>J. Appl. Microbiol.</source><volume>118</volume>, <fpage>1034</fpage>&#8211;<lpage>1047</lpage>. &#160;<pub-id pub-id-type="doi">10.1111/jam.12739</pub-id><pub-id pub-id-type="pmid">25786121</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Gregorio</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>Ju&#225;rez Tom&#225;s</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Nader-Mac&#237;as</surname><given-names>M. E. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Immunomodulation of Lactobacillus Reuteri CRL1324 on Group B Streptococcus Vaginal Colonization in a Murine Experimental Model</article-title>. <source>Am. J. Reprod. Immunol.</source><volume>75</volume>, <fpage>23</fpage>&#8211;<lpage>35</lpage>. &#160;<pub-id pub-id-type="doi">10.1111/aji.12445</pub-id><pub-id pub-id-type="pmid">26547516</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diaz-Dinamarca</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Escobar</surname><given-names>D. F.</given-names></name><name name-style="western"><surname>Soto</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Badilla</surname><given-names>J. F.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Mucosal Vaccination With Lactococcus Lactis-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection Against Group B Streptococcus in a Murine Model</article-title>. <source>Vaccines</source><volume>8</volume>, <fpage>146</fpage>. &#160;<pub-id pub-id-type="doi">10.3390/vaccines8020146</pub-id><pub-id pub-id-type="pmcid">PMC7349291</pub-id><pub-id pub-id-type="pmid">32224855</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dicker</surname><given-names>K. T.</given-names></name><name name-style="western"><surname>Gurski</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>Pradhan-Bhatt</surname><given-names>S.</given-names></name><name name-style="western"><surname>Witt</surname><given-names>R. L.</given-names></name><name name-style="western"><surname>Farach-Carson</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>Hyaluronan: A Simple Polysaccharide With Diverse Biological Functions</article-title>. <source>Acta Biomater.</source><volume>10</volume>, <fpage>1558</fpage>&#8211;<lpage>1570</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.actbio.2013.12.019</pub-id><pub-id pub-id-type="pmid">24361428</pub-id><pub-id pub-id-type="pmcid">PMC3960342</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doran</surname><given-names>K. S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J. C. W.</given-names></name><name name-style="western"><surname>Benoit</surname><given-names>V. M.</given-names></name><name name-style="western"><surname>Eckmann</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name></person-group> (<year>2002</year>). <article-title>Group B Streptococcal &#946;-Hemolysin/Cytolysin Promotes Invasion of Human Lung Epithelial Cells and the Release of Interleukin-8</article-title>. <source>J. Infect. Dis.</source><volume>185</volume>, <fpage>196</fpage>&#8211;<lpage>203</lpage>. &#160;<pub-id pub-id-type="doi">10.1086/338475</pub-id><pub-id pub-id-type="pmid">11807693</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doran</surname><given-names>K. S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G. Y.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name></person-group> (<year>2003</year>). <article-title>Group B Streptococcal &#946;-Hemolysin/Cytolysin Activates Neutrophil Signaling Pathways in Brain Endothelium and Contributes to Development of Meningitis</article-title>. <source>J. Clin. Invest.</source><volume>112</volume>, <fpage>736</fpage>&#8211;<lpage>744</lpage>. &#160;<pub-id pub-id-type="doi">10.1172/jci17335</pub-id><pub-id pub-id-type="pmid">12952922</pub-id><pub-id pub-id-type="pmcid">PMC182187</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>dos Santos</surname><given-names>N. F. B.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>L. R.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>F. J. M. D.</given-names></name><name name-style="western"><surname>de Mattos</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>de Carvalho</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>L. C.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Immunization With a Recombinant BibA Surface Protein Confers Immunity and Protects Mice Against Group B Streptococcus (GBS) Vaginal Colonization</article-title>. <source>Vaccine</source><volume>38</volume>, <fpage>5286</fpage>&#8211;<lpage>5296</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.vaccine.2020.05.076</pub-id><pub-id pub-id-type="pmid">32571719</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doster</surname><given-names>R. S.</given-names></name><name name-style="western"><surname>Sutton</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Aronoff</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Gaddy</surname><given-names>J. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Streptococcus Agalactiae Induces Placental Macrophages to Release Extracellular Traps Loaded With Tissue Remodeling Enzymes <italic toggle="yes">via</italic> an Oxidative Burst-Dependent Mechanism</article-title>. <source>MBio</source><volume>9</volume> (<issue>6</issue>), <page-range>e02084&#8211;18</page-range>. &#160;<pub-id pub-id-type="doi">10.1128/mBio.02084-18</pub-id><pub-id pub-id-type="pmcid">PMC6247082</pub-id><pub-id pub-id-type="pmid">30459195</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dusio</surname><given-names>G. F.</given-names></name><name name-style="western"><surname>Cardani</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zanobbio</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mantovani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Luchini</surname><given-names>P.</given-names></name><name name-style="western"><surname>Battini</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Stimulation of TLRs by LMW-HA Induces Self-Defense Mechanisms in Vaginal Epithelium</article-title>. <source>Immunol. Cell Biol.</source><volume>89</volume>, <fpage>630</fpage>&#8211;<lpage>639</lpage>. &#160;<pub-id pub-id-type="doi">10.1038/icb.2010.140</pub-id><pub-id pub-id-type="pmid">21102537</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Klesius</surname><given-names>P. H.</given-names></name><name name-style="western"><surname>Pasnik</surname><given-names>D. J.</given-names></name><name name-style="western"><surname>Bohnsack</surname><given-names>J. F.</given-names></name></person-group> (<year>2009</year>). <article-title>Human Streptococcus Agalactiae Isolate in Nile Tilapia (Oreochromis Niloticus)</article-title>. <source>Emerg. Infect. Dis.</source><volume>15</volume>, <fpage>774</fpage>&#8211;<lpage>776</lpage>. &#160;<pub-id pub-id-type="doi">10.3201/eid1505.080222</pub-id><pub-id pub-id-type="pmid">19402966</pub-id><pub-id pub-id-type="pmcid">PMC2687030</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farr</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sustr</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rosicky</surname><given-names>I.</given-names></name><name name-style="western"><surname>Graf</surname><given-names>A.</given-names></name><name name-style="western"><surname>Makristathis</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy</article-title>. <source>Sci. Rep.</source><volume>10</volume> (<issue>1</issue>), <fpage>19745</fpage>. &#160;<pub-id pub-id-type="doi">10.1038/s41598-020-76896-4</pub-id><pub-id pub-id-type="pmid">33184437</pub-id><pub-id pub-id-type="pmcid">PMC7665007</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flaherty</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>Magel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aronoff</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Gaddy</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Petroff</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Manning</surname><given-names>S. D.</given-names></name></person-group> (<year>2019</year>). <article-title>Modulation of Death and Inflammatory Signaling in Decidual Stromal Cells Following Exposure to Group B Streptococcus</article-title>. <source>Infect. Immun.</source><volume>87</volume> (<issue>12</issue>), <elocation-id>e00729&#8211;19</elocation-id>. <pub-id pub-id-type="doi">10.1128/IAI.00729-19</pub-id><pub-id pub-id-type="pmid">31548323</pub-id><pub-id pub-id-type="pmcid">PMC6867844</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pawlowsk</surname><given-names>i. A.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bell</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kitson</surname><given-names>G.</given-names></name><name name-style="western"><surname>Darsley</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Safety and Immunogenicity of a Prototype Recombinant Alpha-Like Protein Subunit Vaccine (GBS-NN) Against Group B Streptococcus in a Randomised Placebo-Controlled Double-Blind Phase 1 Trial in Healthy Adult Women</article-title>. <source>Vaccine</source><volume>39</volume>, <fpage>4489</fpage>&#8211;<lpage>4499</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/J.VACCINE.2021.06.046</pub-id><pub-id pub-id-type="pmid">34215454</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Francois Watkins</surname><given-names>L. K.</given-names></name><name name-style="western"><surname>McGee</surname><given-names>L.</given-names></name><name name-style="western"><surname>Schrag</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Beall</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jain</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Pondo</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United State</article-title><article-title>-2016</article-title>. <source>JAMA Intern. Med.</source><volume>179</volume>, <fpage>479</fpage>&#8211;<lpage>488</lpage>. &#160;<pub-id pub-id-type="doi">10.1001/jamainternmed.2018.7269</pub-id><pub-id pub-id-type="pmcid">PMC6450309</pub-id><pub-id pub-id-type="pmid">30776079</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabrielsen</surname><given-names>C.</given-names></name><name name-style="western"><surname>M&#230;land</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Lyng</surname><given-names>R. V.</given-names></name><name name-style="western"><surname>Radtke</surname><given-names>A.</given-names></name><name name-style="western"><surname>Afset</surname><given-names>J. E.</given-names></name></person-group> (<year>2017</year>). <article-title>Molecular Characteristics of Streptococcus Agalactiae Strains Deficient in Alpha-Like Protein Encoding Genes</article-title>. <source>J. Med. Microbiol.</source><volume>66</volume>, <fpage>26</fpage>&#8211;<lpage>33</lpage>. &#160;<pub-id pub-id-type="doi">10.1099/JMM.0.000412</pub-id><pub-id pub-id-type="pmid">28032541</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gajer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Brotman</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sch&#252;tte</surname><given-names>U. M. E.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Temporal Dynamics of the Human Vaginal Microbiota</article-title>. <source>Sci. Transl. Med.</source><volume>4</volume> (<issue>132</issue>), <fpage>132ra52</fpage>. &#160;<pub-id pub-id-type="doi">10.1126/scitranslmed.3003605</pub-id><pub-id pub-id-type="pmcid">PMC3722878</pub-id><pub-id pub-id-type="pmid">22553250</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gendrin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vornhagen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Whidbey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Boldenow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Santana-Ufret</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Mast Cell Degranulation by a Hemolytic Lipid Toxin Decreases GBS Colonization and Infection</article-title>. <source>Sci. Adv.</source><volume>1</volume> (<issue>6</issue>), <elocation-id>e1400225</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1126/sciadv.1400225</pub-id><pub-id pub-id-type="pmid">26425734</pub-id><pub-id pub-id-type="pmcid">PMC4584422</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>R. L.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name><name name-style="western"><surname>Rubens</surname><given-names>C. E.</given-names></name><name name-style="western"><surname>McMenamin</surname><given-names>P.</given-names></name></person-group> (<year>1999</year>). <article-title>Group B Streptococcal &#946;-Hemolysin Promotes Injury of Lung Microvascular Endothelial Cells</article-title>. <source>Pediatr. Res.</source><volume>45</volume>, <fpage>626</fpage>&#8211;<lpage>634</lpage>. &#160;<pub-id pub-id-type="doi">10.1203/00006450-199905010-00003</pub-id><pub-id pub-id-type="pmid">10231855</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>L. R.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mysorekar</surname><given-names>I. U.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>A. L.</given-names></name></person-group> (<year>2021</year>). <article-title>Gardnerella Vaginalis Promotes Group B Streptococcus Vaginal Colonization, Enabling Ascending Uteroplacental Infection in Pregnant Mice</article-title>. <source>Am. J. Obstetrics Gynecol. (Mosby Inc.)</source><volume>224</volume> (<issue>5</issue>), <fpage>530.e1</fpage>&#8211;<lpage>530.e17</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ajog.2020.11.032</pub-id><pub-id pub-id-type="pmcid">PMC8555936</pub-id><pub-id pub-id-type="pmid">33248136</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomez-Lopez</surname><given-names>N.</given-names></name><name name-style="western"><surname>Romero</surname><given-names>R.</given-names></name><name name-style="western"><surname>Garcia-Flores</surname><given-names>V.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Leng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Alhousseini</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Amniotic Fluid Neutrophils can Phagocytize Bacteria: A Mechanism for Microbial Killing in the Amniotic Cavity</article-title>. <source>Am. J. Reprod. Immunol.</source><volume>78</volume> (<issue>4</issue>), <elocation-id>10.1111/aji.12723</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1111/aji.12723</pub-id><pub-id pub-id-type="pmcid">PMC5623137</pub-id><pub-id pub-id-type="pmid">28703488</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gravett</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Witkin</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Haluska</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>J. E. L.</given-names></name><name name-style="western"><surname>Cook</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Novy</surname><given-names>M. J.</given-names></name></person-group> (<year>1994</year>). <article-title>An Experimental Model for Intraamniotic Infection and Preterm Labor in Rhesus Monkeys</article-title>. <source>Am. J. Obstet. Gynecol.</source><volume>171</volume>, <fpage>1660</fpage>&#8211;<lpage>1667</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/0002-9378(94)90418-9</pub-id><pub-id pub-id-type="pmid">7802084</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>J.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>N. H.</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>L.</given-names></name><name name-style="western"><surname>Seale</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Lamagni</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bianchi-Jassir</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-Analyses</article-title>. <source>Clin. Infect. Dis.</source><volume>65</volume>, <fpage>S112</fpage>&#8211;<lpage>S124</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/cid/cix660</pub-id><pub-id pub-id-type="pmid">29117328</pub-id><pub-id pub-id-type="pmcid">PMC5850000</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hays</surname><given-names>C.</given-names></name><name name-style="western"><surname>Louis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Plainvert</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dmytruk</surname><given-names>N.</given-names></name><name name-style="western"><surname>Touak</surname><given-names>G.</given-names></name><name name-style="western"><surname>Trieu-Cuot</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France</article-title>. <source>Antimicrob. Agents Chemother.</source><volume>60</volume>, <fpage>7424</fpage>&#8211;<lpage>7430</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/AAC.01374-16</pub-id><pub-id pub-id-type="pmid">27736761</pub-id><pub-id pub-id-type="pmcid">PMC5119025</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hein</surname><given-names>M.</given-names></name><name name-style="western"><surname>Helmig</surname><given-names>R. B.</given-names></name><name name-style="western"><surname>Sch&#248;nheyder</surname><given-names>H. C.</given-names></name><name name-style="western"><surname>Ganz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Uldbjerg</surname><given-names>N.</given-names></name></person-group> (<year>2001</year>). <article-title>An <italic toggle="yes">In Vitro</italic> Study of Antibacterial Properties of the Cervical Mucus Plug in Pregnancy</article-title>. <source>Am. J. Obstet. Gynecol.</source><volume>185</volume>, <fpage>586</fpage>&#8211;<lpage>592</lpage>. &#160;<pub-id pub-id-type="doi">10.1067/mob.2001.116685</pub-id><pub-id pub-id-type="pmid">11568782</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hein</surname><given-names>M.</given-names></name><name name-style="western"><surname>Valore</surname><given-names>E. V.</given-names></name><name name-style="western"><surname>Helmig</surname><given-names>R. B.</given-names></name><name name-style="western"><surname>Uldbjerg</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ganz</surname><given-names>T.</given-names></name></person-group> (<year>2002</year>). <article-title>Antimicrobial Factors in the Cervical Mucus Plug</article-title>. <source>Am. J. Obstet. Gynecol.</source><volume>187</volume>, <fpage>137</fpage>&#8211;<lpage>144</lpage>. &#160;<pub-id pub-id-type="doi">10.1067/mob.2002.123034</pub-id><pub-id pub-id-type="pmid">12114901</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Niu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Na</surname><given-names>R.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Evaluation of the Inhibitory Effects of Lactobacillus Gasseri and Lactobacillus Crispatus on the Adhesion of Seven Common Lower Genital Tract Infection-Causing Pathogens to Vaginal Epithelial Cells</article-title>. <source>Front. Med.</source><volume>7</volume>, <elocation-id>284</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fmed.2020.00284</pub-id><pub-id pub-id-type="pmcid">PMC7317292</pub-id><pub-id pub-id-type="pmid">32637420</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hensler</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G. Y.</given-names></name><name name-style="western"><surname>Sobczak</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benirschke</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name><name name-style="western"><surname>Heldt</surname><given-names>G. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Virulence Role of Group B Streptococcus &#946;-Hemolysin/Cytolysin in a Neonatal Rabbit Model of Early-Onset Pulmonary Infection</article-title>. <source>J. Infect. Dis.</source><volume>191</volume>, <fpage>1287</fpage>&#8211;<lpage>1291</lpage>. &#160;<pub-id pub-id-type="doi">10.1086/428946</pub-id><pub-id pub-id-type="pmid">15776375</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hillier</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Ferrieri</surname><given-names>P.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Ewell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ferris</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fine</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III</article-title>. <source>Clin. Infect. Dis.</source><volume>68</volume>, <fpage>2079</fpage>&#8211;<lpage>2086</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/cid/ciy838</pub-id><pub-id pub-id-type="pmid">30281066</pub-id><pub-id pub-id-type="pmcid">PMC7317289</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Toler</surname><given-names>E.</given-names></name><name name-style="western"><surname>DeLong</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mafunda</surname><given-names>N. A.</given-names></name><name name-style="western"><surname>Bloom</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Zierden</surname><given-names>H. C.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>The Cervicovaginal Mucus Barrier to HIV-1 Is Diminished in Bacterial Vaginosis</article-title>. <source>PloS Pathog.</source><volume>16</volume> (<issue>1</issue>), <elocation-id>e1008236</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1371/journal.ppat.1008236</pub-id><pub-id pub-id-type="pmid">31971984</pub-id><pub-id pub-id-type="pmcid">PMC6999914</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y. Y.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>W. C.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H. C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>W. C.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Oral Lactobacillus Rhamnosus GR-1 and Lactobacillus Reuteri RC-14 to Reduce Group B Streptococcus Colonization in Pregnant Women: A Randomized Controlled Trial</article-title>. <source>Taiwan J. Obstet. Gynecol.</source><volume>55</volume>, <fpage>515</fpage>&#8211;<lpage>518</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.tjog.2016.06.003</pub-id><pub-id pub-id-type="pmid">27590374</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>E. A.</given-names></name><name name-style="western"><surname>Anipindi</surname><given-names>V. C.</given-names></name><name name-style="western"><surname>Francis</surname><given-names>I.</given-names></name><name name-style="western"><surname>Shaik-Dasthagirisaheb</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Specific Binding to Differentially Expressed Human Carcinoembryonic Antigenrelated Cell Adhesion Molecules Determines the Outcome of Neisseria Gonorrhoeae Infections Along the Female Reproductive Tract</article-title>. <source>Infect. Immun.</source><volume>86</volume> (<issue>8</issue>), <page-range>e00092&#8211;18</page-range>. &#160;<pub-id pub-id-type="doi">10.1128/IAI.00092-18</pub-id><pub-id pub-id-type="pmcid">PMC6056862</pub-id><pub-id pub-id-type="pmid">29760215</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Cieslewicz</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Kasper</surname><given-names>D. L.</given-names></name><name name-style="western"><surname>Wessels</surname><given-names>M. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Regulation of Virulence by a Two-Component System in Group B Streptococcus</article-title>. <source>J.&#160;Bacteriol.</source><volume>187</volume>, <fpage>1105</fpage>&#8211;<lpage>1113</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/JB.187.3.1105-1113.2005</pub-id><pub-id pub-id-type="pmid">15659687</pub-id><pub-id pub-id-type="pmcid">PMC545708</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wessels</surname><given-names>M. R.</given-names></name></person-group> (<year>2014</year>). <article-title>BsaB, A Novel Adherence Factor of Group B Streptococcus</article-title>. <source>Infect. Immun.</source><volume>82</volume>, <fpage>1007</fpage>&#8211;<lpage>1016</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/IAI.01014-13</pub-id><pub-id pub-id-type="pmid">24343649</pub-id><pub-id pub-id-type="pmcid">PMC3957996</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jisuvei</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Osoti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Njeri</surname><given-names>M. A.</given-names></name></person-group> (<year>2020</year>). <article-title>Prevalence, Antimicrobial Susceptibility Patterns, Serotypes and Risk Factors for Group B Streptococcus Rectovaginal Isolates Among Pregnant Women at Kenyatta National Hospital, Kenya; A Cross-Sectional Study</article-title>. <source>BMC Infect. Dis.</source><volume>20</volume> (<issue>1</issue>), <fpage>302</fpage>. &#160;<pub-id pub-id-type="doi">10.1186/s12879-020-05035-1</pub-id><pub-id pub-id-type="pmid">32321444</pub-id><pub-id pub-id-type="pmcid">PMC7178604</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bohnsack</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Kunst</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Multilocus Sequence Typing System for Group B Streptococcus</article-title>. <source>J. Clin. Microbiol.</source><volume>41</volume>, <fpage>2530</fpage>&#8211;<lpage>2536</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/JCM.41.6.2530-2536.2003</pub-id><pub-id pub-id-type="pmid">12791877</pub-id><pub-id pub-id-type="pmcid">PMC156480</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>M. Y.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H. R.</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>M. C.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Emerging Serotype III Sequence Type 17 Group B Streptococcus Invasive Infection in Infants: The Clinical Characteristics and Impacts on Outcomes</article-title>. <source>BMC Infect. Dis.</source><volume>19</volume> (<issue>1</issue>), <fpage>538</fpage>. &#160;<pub-id pub-id-type="doi">10.1186/s12879-019-4177-y</pub-id><pub-id pub-id-type="pmid">31216993</pub-id><pub-id pub-id-type="pmcid">PMC6585028</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolar</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Kyme</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tseng</surname><given-names>C. W.</given-names></name><name name-style="western"><surname>Soliman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Group B Streptococcus Evades Host Immunity by Degrading Hyaluronan</article-title>. <source>Cell Host Microbe</source><volume>18</volume>, <fpage>694</fpage>&#8211;<lpage>704</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.chom.2015.11.001</pub-id><pub-id pub-id-type="pmid">26651945</pub-id><pub-id pub-id-type="pmcid">PMC4683412</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kothary</surname><given-names>V.</given-names></name><name name-style="western"><surname>Doster</surname><given-names>R. S.</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>K. L.</given-names></name><name name-style="western"><surname>Romano-Keeler</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Group B Streptococcus Induces Neutrophil Recruitment to Gestational Tissues and Elaboration of Extracellular Traps and Nutritional Immunity</article-title>. <source>Front. Cell. Infect. Microbiol.</source><volume>7</volume>, <elocation-id>19</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fcimb.2017.00019</pub-id><pub-id pub-id-type="pmid">28217556</pub-id><pub-id pub-id-type="pmcid">PMC5289994</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubota</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nojima</surname><given-names>M.</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Vaginal Bacterial Flora of Pregnant Women Colonized With Group B Streptococcus</article-title>. <source>J. Infect. Chemother.</source><volume>8</volume>, <fpage>326</fpage>&#8211;<lpage>330</lpage>. &#160;<pub-id pub-id-type="doi">10.1007/s10156-002-0190-x</pub-id><pub-id pub-id-type="pmid">12525892</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwatra</surname><given-names>G.</given-names></name><name name-style="western"><surname>Adrian</surname><given-names>P. V.</given-names></name><name name-style="western"><surname>Shiri</surname><given-names>T.</given-names></name><name name-style="western"><surname>Buchmann</surname><given-names>E. J.</given-names></name><name name-style="western"><surname>Cutland</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Madhi</surname><given-names>S. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Natural Acquired Humoral Immunity Against Serotype-Specific Group B Streptococcus Rectovaginal Colonization Acquisition in Pregnant Women</article-title>. <source>Clin. Microbiol. Infect.</source><volume>21</volume>, <fpage>568.e13</fpage>&#8211;<lpage>568.e21</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.cmi.2015.01.030</pub-id><pub-id pub-id-type="pmid">25680313</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lacroix</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gouyer</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gottrand</surname><given-names>F.</given-names></name><name name-style="western"><surname>Desseyn</surname><given-names>J. L.</given-names></name></person-group> (<year>2020</year>). <article-title>The Cervicovaginal Mucus Barrier</article-title>. <source>Int. J. Mol. Sci.</source><volume>21</volume>, <fpage>1</fpage>&#8211;<lpage>23</lpage>. &#160;<pub-id pub-id-type="doi">10.3390/ijms21218266</pub-id><pub-id pub-id-type="pmcid">PMC7663572</pub-id><pub-id pub-id-type="pmid">33158227</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamy</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Zouine</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fert</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vergassola</surname><given-names>M.</given-names></name><name name-style="western"><surname>Couve</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>CovS/CovR of Group B Streptococcus: A Two-Component Global Regulatory System Involved in Virulence</article-title>. <source>Mol. Microbiol.</source><volume>54</volume>, <fpage>1250</fpage>&#8211;<lpage>1268</lpage>. &#160;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04365.x</pub-id><pub-id pub-id-type="pmid">15554966</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lancefield</surname><given-names>R. C.</given-names></name></person-group> (<year>1934</year>). <article-title>A Serological Differentiation of Specific Types of Bovine Hemolytic Streptococci (Group B)</article-title>. <source>J. Exp. Med.</source><volume>59</volume>, <fpage>441</fpage>&#8211;<lpage>458</lpage>. &#160;<pub-id pub-id-type="doi">10.1084/jem.59.4.441</pub-id><pub-id pub-id-type="pmid">19870257</pub-id><pub-id pub-id-type="pmcid">PMC2132330</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lannon</surname><given-names>S. M. R.</given-names></name><name name-style="western"><surname>Vanderhoeven</surname><given-names>J. P.</given-names></name><name name-style="western"><surname>Eschenbach</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Gravett</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Waldorf</surname><given-names>K. M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Synergy and Interactions Among Biological Pathways Leading to Preterm Premature Rupture of Membranes</article-title>. <source>Reprod. Sci.</source><volume>21</volume>, <fpage>1215</fpage>&#8211;<lpage>1227</lpage>. &#160;<pub-id pub-id-type="doi">10.1177/1933719114534535</pub-id><pub-id pub-id-type="pmid">24840939</pub-id><pub-id pub-id-type="pmcid">PMC5933184</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Doare</surname><given-names>K.</given-names></name><name name-style="western"><surname>O&#8217;Driscoll</surname><given-names>M.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>K.</given-names></name><name name-style="western"><surname>Seedat</surname><given-names>F.</given-names></name><name name-style="western"><surname>Russell</surname><given-names>N. J.</given-names></name><name name-style="western"><surname>Seale</surname><given-names>A. C.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review</article-title>. <source>Clin. Infect. Dis.</source><volume>65</volume>, <fpage>S143</fpage>&#8211;<lpage>S151</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/cid/cix654</pub-id><pub-id pub-id-type="pmid">29117324</pub-id><pub-id pub-id-type="pmcid">PMC5850619</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>D. C.</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Romero</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tarca</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Bhatti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gervasi</surname><given-names>M. T.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Protein Profiling Underscores Immunological Functions of Uterine Cervical Mucus Plug in Human Pregnancy</article-title>. <source>J. Proteomics</source><volume>74</volume>, <fpage>817</fpage>&#8211;<lpage>828</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.jprot.2011.02.025</pub-id><pub-id pub-id-type="pmid">21362502</pub-id><pub-id pub-id-type="pmcid">PMC3111960</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lembo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gurney</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Burnside</surname><given-names>K.</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Los Reyes</surname><given-names>M.</given-names></name><name name-style="western"><surname>Connelly</surname><given-names>J. E.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Regulation of CovR Expression in Group B Streptococcus Impacts Blood-Brain Barrier Penetration</article-title>. <source>Mol. Microbiol.</source><volume>77</volume>, <fpage>431</fpage>&#8211;<lpage>443</lpage>. &#160;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07215.x</pub-id><pub-id pub-id-type="pmid">20497331</pub-id><pub-id pub-id-type="pmcid">PMC2909351</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>G. Y.</given-names></name><name name-style="western"><surname>Doran</surname><given-names>K. S.</given-names></name><name name-style="western"><surname>Lawrence</surname><given-names>T.</given-names></name><name name-style="western"><surname>Turkson</surname><given-names>N.</given-names></name><name name-style="western"><surname>Puliti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tissi</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Sword and Shield: Linked Group B Streptococcal &#946;-Hemolysin/Cytolysin and Carotenoid Pigment Function to Subvert Host Phagocyte Defense</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>101</volume>, <fpage>14491</fpage>&#8211;<lpage>14496</lpage>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.0406143101</pub-id><pub-id pub-id-type="pmid">15381763</pub-id><pub-id pub-id-type="pmcid">PMC521972</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Effect of Oral Lactobacillusrhamnosus GR-1 and Lactobacillusreuteri RC-14 on Vaginal Group B Streptococcus Colonization and Vaginal Microbiome in Late Pregnancy</article-title>. <source>Nan Fang Yi Ke Da Xue Xue Bao</source><volume>40</volume>, <fpage>1753</fpage>&#8211;<lpage>1759</lpage>. &#160;<pub-id pub-id-type="doi">10.12122/j.issn.1673-4254.2020.12.09</pub-id><pub-id pub-id-type="pmid">33380389</pub-id><pub-id pub-id-type="pmcid">PMC7835693</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madanchi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Shoushtari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kashani</surname><given-names>H. H.</given-names></name><name name-style="western"><surname>Sardari</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Antimicrobial Peptides of the Vaginal Innate Immunity and Their Role in the Fight Against Sexually Transmitted Diseases</article-title>. <source>New Microbes New Infect.</source><volume>34</volume>, <elocation-id>100627</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1016/j.nmni.2019.100627</pub-id><pub-id pub-id-type="pmid">31993204</pub-id><pub-id pub-id-type="pmcid">PMC6976936</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madrid</surname><given-names>L.</given-names></name><name name-style="western"><surname>Seale</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Kohli-Lynch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Edmond</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Lawn</surname><given-names>J. E.</given-names></name><name name-style="western"><surname>Heath</surname><given-names>P. T.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-Analyses</article-title>. <source>Clin. Infect. Dis.</source><volume>65</volume>, <fpage>S160</fpage>&#8211;<lpage>S172</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/cid/cix656</pub-id><pub-id pub-id-type="pmid">29117326</pub-id><pub-id pub-id-type="pmcid">PMC5850457</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Mahendroo</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Cervical Hyaluronan Biology in Pregnancy, Parturition and Preterm Birth</article-title>. <source>Matrix Biol.</source><fpage>78</fpage>&#8211;<lpage>79, 24&#8211;31</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.matbio.2018.03.002</pub-id><pub-id pub-id-type="pmcid">PMC6120812</pub-id><pub-id pub-id-type="pmid">29510230</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marques</surname><given-names>M. B.</given-names></name><name name-style="western"><surname>Kasper</surname><given-names>D. L.</given-names></name><name name-style="western"><surname>Pangburn</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Wessels</surname><given-names>M. R.</given-names></name></person-group> (<year>1992</year>). <article-title>Prevention of C3 Deposition by Capsular Polysaccharide Is a Virulence Mechanism of Type III Group B Streptococci</article-title>. <source>Infect. Immun.</source><volume>60</volume>, <fpage>3986</fpage>&#8211;<lpage>3993</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/iai.60.10.3986-3993.1992</pub-id><pub-id pub-id-type="pmid">1398910</pub-id><pub-id pub-id-type="pmcid">PMC257427</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;n</surname><given-names>V.</given-names></name><name name-style="western"><surname>C&#225;rdenas</surname><given-names>N.</given-names></name><name name-style="western"><surname>Oca&#241;a</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Arroyo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Beltr&#225;n</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Rectal and Vaginal Eradication of Streptococcus Agalactiae (Gbs) in Pregnant Women by Using Lactobacillus Salivarius Cect 9145, A Target-Specific Probiotic Strain</article-title>. <source>Nutrients</source><volume>11</volume> (<issue>4</issue>), <fpage>810</fpage>. &#160;<pub-id pub-id-type="doi">10.3390/nu11040810</pub-id><pub-id pub-id-type="pmcid">PMC6521265</pub-id><pub-id pub-id-type="pmid">30974819</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rioux</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gagnon</surname><given-names>E.</given-names></name><name name-style="western"><surname>Boyer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hamel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Charland</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Protection From Group B Streptococcal Infection in Neonatal Mice by Maternal Immunization With Recombinant Sip Protein</article-title>. <source>Infect. Immun.</source><volume>70</volume>, <fpage>4897</fpage>&#8211;<lpage>4901</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/IAI.70.9.4897-4901.2002</pub-id><pub-id pub-id-type="pmid">12183534</pub-id><pub-id pub-id-type="pmcid">PMC128249</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marziali</surname><given-names>G.</given-names></name><name name-style="western"><surname>Foschi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Parolin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vitali</surname><given-names>B.</given-names></name><name name-style="western"><surname>Marangoni</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title><italic toggle="yes">In-Vitro</italic> Effect of Vaginal Lactobacilli Against Group B Streptococcus</article-title>. <source>Microb. Pathog.</source><volume>136</volume>, <elocation-id>103692</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1016/j.micpath.2019.103692</pub-id><pub-id pub-id-type="pmid">31445119</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCartney</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Kapur</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liggitt</surname><given-names>H. D.</given-names></name><name name-style="western"><surname>Baldessari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Orvis</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Amniotic Fluid Interleukin 6 and Interleukin 8 Are Superior Predictors of Fetal Lung Injury Compared With Maternal or Fetal Plasma Cytokines or Placental Histopathology in a Nonhuman Primate Model</article-title>. <source>Am. J. Obstet. Gynecol.</source><volume>225</volume> (<issue>1</issue>), <fpage>89.e1</fpage>&#8211;<lpage>89.e16</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ajog.2020.12.1214</pub-id><pub-id pub-id-type="pmid">33412130</pub-id><pub-id pub-id-type="pmcid">PMC8254735</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meehan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cunney</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cafferkey</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular Epidemiology of Group B Streptococci in Ireland Reveals a Diverse Population With Evidence of Capsular Switching</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source><volume>33</volume>, <fpage>1155</fpage>&#8211;<lpage>1162</lpage>. &#160;<pub-id pub-id-type="doi">10.1007/s10096-014-2055-5</pub-id><pub-id pub-id-type="pmid">24469423</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyn</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>Krohn</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Hillier</surname><given-names>S. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Rectal Colonization by Group B Streptococcus as a Predictor of Vaginal Colonization</article-title>. <source>Am. J. Obstet. Gynecol.</source><volume>201</volume>, <fpage>76.e1</fpage>&#8211;<lpage>76.e7</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ajog.2009.02.011</pub-id><pub-id pub-id-type="pmid">19371857</pub-id><pub-id pub-id-type="pmcid">PMC2770838</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michon</surname><given-names>F.</given-names></name><name name-style="western"><surname>Uitz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>A.</given-names></name><name name-style="western"><surname>D&#8217;Ambra</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Laude-Sharp</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Group B Streptococcal Type II and III Conjugate Vaccines: Physicochemical Properties That Influence Immunogenicity</article-title>. <source>Clin. Vaccine Immunol.</source><volume>13</volume>, <fpage>936</fpage>&#8211;<lpage>943</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/CVI.00122-06</pub-id><pub-id pub-id-type="pmid">16893995</pub-id><pub-id pub-id-type="pmcid">PMC1539122</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mistou</surname><given-names>M. Y.</given-names></name><name name-style="western"><surname>Dramsi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Brega</surname><given-names>S.</given-names></name><name name-style="western"><surname>Poyart</surname><given-names>C.</given-names></name><name name-style="western"><surname>Trieu-Cuot</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular Dissection of the Seca2 Locus of Group B Streptococcus Reveals That Glycosylation of the Srr1 LPXTG Protein Is Required for Full Virulence</article-title>. <source>J.&#160;Bacteriol.</source><volume>191</volume>, <fpage>4195</fpage>&#8211;<lpage>4206</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/JB.01673-08</pub-id><pub-id pub-id-type="pmid">19395494</pub-id><pub-id pub-id-type="pmcid">PMC2698466</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Group B Streptococcus Colonization Induces Prevotella and Megasphaera Abundance-Featured Vaginal Microbiome Compositional Change in Non-Pregnant Women</article-title>. <source>PeerJ</source><volume>7</volume>, <elocation-id>e7474</elocation-id>. &#160;<pub-id pub-id-type="doi">10.7717/peerj.7474</pub-id><pub-id pub-id-type="pmid">31440433</pub-id><pub-id pub-id-type="pmcid">PMC6699484</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagano</surname><given-names>N.</given-names></name><name name-style="western"><surname>Koide</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Taniguchi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>H.</given-names></name><name name-style="western"><surname>Maeyama</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Population-Level Transition of Capsular Polysaccharide Types Among Sequence Type 1 Group B Streptococcus Isolates With Reduced Penicillin Susceptibility During a Long-Term Hospital Epidemic</article-title>. <source>Int. J. Antimicrob. Agents</source><volume>53</volume>, <fpage>203</fpage>&#8211;<lpage>210</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2018.11.003</pub-id><pub-id pub-id-type="pmid">30414439</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanduri</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Petit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Smelser</surname><given-names>C.</given-names></name><name name-style="western"><surname>Apostol</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alden</surname><given-names>N. B.</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>L. H.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United State</article-title><article-title>to 2015: Multistate Laboratory and Population-Based Surveillance</article-title>. <source>JAMA Pediatr.</source><volume>173</volume>, <fpage>224</fpage>&#8211;<lpage>233</lpage>. &#160;<pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.4826</pub-id><pub-id pub-id-type="pmcid">PMC6439883</pub-id><pub-id pub-id-type="pmid">30640366</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neemuchwala</surname><given-names>A.</given-names></name><name name-style="western"><surname>Teatero</surname><given-names>S.</given-names></name><name name-style="western"><surname>Athey</surname><given-names>T. B. T.</given-names></name><name name-style="western"><surname>McGeer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fittipaldi</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Capsular Switching and Other Large-Scale Recombination Events in Invasive Sequence Type 1 Group B Streptococcus</article-title>. <source>Emerg. Infect. Dis.</source><volume>22</volume>, <fpage>1941</fpage>&#8211;<lpage>1944</lpage>. &#160;<pub-id pub-id-type="doi">10.3201//eid2211.152064</pub-id><pub-id pub-id-type="pmid">27767925</pub-id><pub-id pub-id-type="pmcid">PMC5088006</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>R. L.</given-names></name><name name-style="western"><surname>Chi</surname><given-names>E. Y.</given-names></name><name name-style="western"><surname>Framson</surname><given-names>P. E.</given-names></name><name name-style="western"><surname>Hulse</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rubens</surname><given-names>C. E.</given-names></name></person-group> (<year>1996</year>). <article-title>Group B Streptococcal Beta-Hemolysin Expression Is Associated With Injury of Lung Epithelial Cells</article-title>. <source>Infect. Immun.</source><volume>64</volume>, <fpage>3818</fpage>&#8211;<lpage>3826</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/iai.64.9.3818-3826.1996</pub-id><pub-id pub-id-type="pmid">8751934</pub-id><pub-id pub-id-type="pmcid">PMC174298</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>R. L.</given-names></name><name name-style="western"><surname>Rubens</surname><given-names>C. E.</given-names></name></person-group> (<year>1997</year>). <article-title>The Role of Group B Streptococci &#946;-Hemolysin Expression in Newborn Lung Injury</article-title>. <source>Adv. Exp. Med. Biol. (Springer New York LLC)</source>, <fpage>627</fpage>&#8211;<lpage>630</lpage>. &#160;<pub-id pub-id-type="doi">10.1007/978-1-4899-1825-3_146</pub-id><pub-id pub-id-type="pmid">9331730</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nuccitelli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cozzi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gourlay</surname><given-names>L. J.</given-names></name><name name-style="western"><surname>Donnarumma</surname><given-names>D.</given-names></name><name name-style="western"><surname>Necchi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Norais</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Structure-Based Approach to Rationally Design a Chimeric Protein for an Effective Vaccine Against Group B Streptococcus Infections</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>108</volume>, <fpage>10278</fpage>&#8211;<lpage>10283</lpage>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1106590108</pub-id><pub-id pub-id-type="pmid">21593422</pub-id><pub-id pub-id-type="pmcid">PMC3121859</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oldrini</surname><given-names>D.</given-names></name><name name-style="western"><surname>del Bino</surname><given-names>L.</given-names></name><name name-style="western"><surname>Arda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carboni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Henriques</surname><given-names>P.</given-names></name><name name-style="western"><surname>Angiolini</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan&#8211;Conjugate Vaccine</article-title>. <source>Chem. - A Eur. J.</source><volume>26</volume>, <fpage>7018</fpage>&#8211;<lpage>7025</lpage>. &#160;<pub-id pub-id-type="doi">10.1002/chem.202000284</pub-id><pub-id pub-id-type="pmcid">PMC7317837</pub-id><pub-id pub-id-type="pmid">32058627</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olmsted</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Meyn</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>Rohan</surname><given-names>L. C.</given-names></name><name name-style="western"><surname>Hillier</surname><given-names>S. L.</given-names></name></person-group> (<year>2003</year>). <article-title>Glycosidase and Proteinase Activity of Anaerobic Gram-Negative Bacteria Isolated From Women With Bacterial Vaginosis</article-title>. <source>Sex Transm. Dis.</source><volume>30</volume>, <fpage>257</fpage>&#8211;<lpage>261</lpage>. &#160;<pub-id pub-id-type="doi">10.1097/00007435-200303000-00016</pub-id><pub-id pub-id-type="pmid">12616147</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Traynor</surname><given-names>V.</given-names></name><name name-style="western"><surname>Georgiou</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>The Impact of Oral Probiotics on Vaginal Group B Streptococcal Colonisation Rates in Pregnant Women: A Pilot Randomised Control Study</article-title>. <source>Women Birth</source><volume>31</volume>, <fpage>31</fpage>&#8211;<lpage>37</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.wombi.2017.06.012</pub-id><pub-id pub-id-type="pmid">28668229</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onderdonk</surname><given-names>A. B.</given-names></name><name name-style="western"><surname>Delaney</surname><given-names>M. L.</given-names></name><name name-style="western"><surname>Fichorova</surname><given-names>R. N.</given-names></name></person-group> (<year>2016</year>). <article-title>The Human Microbiome During Bacterial Vaginosis</article-title>. <source>Clin. Microbiol. Rev.</source><volume>29</volume>, <fpage>223</fpage>&#8211;<lpage>238</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/CMR.00075-15</pub-id><pub-id pub-id-type="pmid">26864580</pub-id><pub-id pub-id-type="pmcid">PMC4786887</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortiz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>L.</given-names></name><name name-style="western"><surname>Barberis</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Effect of Two Probiotic Strains of Lactobacillus on <italic toggle="yes">In Vitro</italic> Adherence of Listeria Monocytogenes, Streptococcus Agalactiae, and Staphylococcus Aureus to Vaginal Epithelial Cells</article-title>. <source>Curr. Microbiol.</source><volume>68</volume>, <fpage>679</fpage>&#8211;<lpage>684</lpage>. &#160;<pub-id pub-id-type="doi">10.1007/s00284-014-0524-9</pub-id><pub-id pub-id-type="pmid">24469557</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S. E.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wessels</surname><given-names>M. R.</given-names></name></person-group> (<year>2012</year>). <article-title>CsrRS and Environmental pH Regulate Group B Streptococcus Adherence to Human Epithelial Cells and Extracellular Matrix</article-title>. <source>Infect. Immun.</source><volume>80</volume>, <fpage>3975</fpage>&#8211;<lpage>3984</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/IAI.00699-12</pub-id><pub-id pub-id-type="pmid">22949550</pub-id><pub-id pub-id-type="pmcid">PMC3486057</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patras</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>R&#246;sler</surname><given-names>B.</given-names></name><name name-style="western"><surname>Thoman</surname><given-names>M. L.</given-names></name><name name-style="western"><surname>Doran</surname><given-names>K. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Characterization of Host Immunity During Persistent Vaginal Colonization by Group B Streptococcus</article-title>. <source>Mucosal Immunol.</source><volume>8</volume>, <fpage>1339</fpage>&#8211;<lpage>1348</lpage>. &#160;<pub-id pub-id-type="doi">10.1038/mi.2015.23</pub-id><pub-id pub-id-type="pmid">25850655</pub-id><pub-id pub-id-type="pmcid">PMC4598252</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patras</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N. Y.</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>E. M.</given-names></name><name name-style="western"><surname>Cavaco</surname><given-names>C. K.</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Garg</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Group BStreptococcusCovR Regulation Modulates Host Immune Signalling Pathways to Promote Vaginal Colonization</article-title>. <source>Cell. Microbiol.</source><volume>15</volume>, <fpage>1154</fpage>&#8211;<lpage>1167</lpage>. &#160;<pub-id pub-id-type="doi">10.1111/cmi.12105</pub-id><pub-id pub-id-type="pmid">23298320</pub-id><pub-id pub-id-type="pmcid">PMC3657335</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patron</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gilot</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rong</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hiron</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mereghetti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Camiade</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>Inductors and Regulatory Properties of the Genomic Island-Associated Fru2 Metabolic Operon of Streptococcus Agalactiae</article-title>. <source>Mol. Microbiol.</source><volume>103</volume>, <fpage>678</fpage>&#8211;<lpage>697</lpage>. &#160;<pub-id pub-id-type="doi">10.1111/mmi.13581</pub-id><pub-id pub-id-type="pmid">27870221</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poyart</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lamy</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Boumaila</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fiedler</surname><given-names>F.</given-names></name><name name-style="western"><surname>Trieu-Cuot</surname><given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>Regulation of D-Alanyl-Lipoteichoic Acid Biosynthesis in Streptococcus Agalactiae Involves a Novel Two-Component Regulatory System</article-title>. <source>J.&#160;Bacteriol.</source><volume>183</volume>, <fpage>6324</fpage>&#8211;<lpage>6334</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/JB.183.21.6324-6334.2001</pub-id><pub-id pub-id-type="pmid">11591677</pub-id><pub-id pub-id-type="pmcid">PMC100127</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poyart</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>E.</given-names></name><name name-style="western"><surname>Marceau</surname><given-names>M.</given-names></name><name name-style="western"><surname>Baptista</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jaubert</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lamy</surname><given-names>M. C.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Attenuated Virulence of Streptococcus Agalactiae Deficient in D-Alanyl-Lipoteichoic Acid Is Due to an Increased Susceptibility to Defensins and Phagocytic Cells</article-title>. <source>Mol. Microbiol.</source><volume>49</volume>, <fpage>1615</fpage>&#8211;<lpage>1625</lpage>. &#160;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03655.x</pub-id><pub-id pub-id-type="pmid">12950925</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pritzlaff</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J. C. W.</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>S. P.</given-names></name><name name-style="western"><surname>Tamura</surname><given-names>G. S.</given-names></name><name name-style="western"><surname>Rubens</surname><given-names>C. E.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name></person-group> (<year>2001</year>). <article-title>Genetic Basis for the &#946;-Haemolytic/Cytolytic Activity of Group B Streptococcus</article-title>. <source>Mol. Microbiol.</source><volume>39</volume>, <fpage>236</fpage>&#8211;<lpage>248</lpage>. &#160;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02211.x</pub-id><pub-id pub-id-type="pmid">11136446</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ravel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gajer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Abdo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>G. M.</given-names></name><name name-style="western"><surname>Koenig</surname><given-names>S. S. K.</given-names></name><name name-style="western"><surname>McCulle</surname><given-names>S. L.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Vaginal Microbiome of Reproductive-Age Women</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>108</volume>, <fpage>4680</fpage>&#8211;<lpage>4687</lpage>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1002611107</pub-id><pub-id pub-id-type="pmid">20534435</pub-id><pub-id pub-id-type="pmcid">PMC3063603</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rego</surname><given-names>S.</given-names></name><name name-style="western"><surname>Heal</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Pidwill</surname><given-names>G. R.</given-names></name><name name-style="western"><surname>Till</surname><given-names>M.</given-names></name><name name-style="western"><surname>Robson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lamont</surname><given-names>R. J.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Structural and Functional Analysis of Cell Wall-Anchored Polypeptide Adhesin BspA in Streptococcus Agalactiae</article-title>. <source>J. Biol. Chem.</source><volume>291</volume>, <fpage>15985</fpage>&#8211;<lpage>16000</lpage>. &#160;<pub-id pub-id-type="doi">10.1074/jbc.M116.726562</pub-id><pub-id pub-id-type="pmid">27311712</pub-id><pub-id pub-id-type="pmcid">PMC4965550</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rick</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Aguilar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cortes</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gordillo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Melgar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Samayoa-Reyes</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Group B Streptococci Colonization in Pregnant Guatemalan Women: Prevalence, Risk Factors, and Vaginal Microbiome</article-title>. <source>Open Forum Infect. Dis.</source><volume>4</volume> (<issue>1</issue>), <elocation-id>ofx020</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1093/ofid/ofx020</pub-id><pub-id pub-id-type="pmid">28480290</pub-id><pub-id pub-id-type="pmcid">PMC5414013</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Anders</surname><given-names>A. P.</given-names></name><name name-style="western"><surname>Doster</surname><given-names>R. S.</given-names></name><name name-style="western"><surname>Gill</surname><given-names>E. A.</given-names></name><name name-style="western"><surname>Gnecco</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Holley</surname><given-names>J. M.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Decidual Stromal Cell-Derived PGE2 Regulates Macrophage Responses to Microbial Threat</article-title>. <source>Am. J. Reprod. Immunol.</source><volume>80</volume> (<issue>4</issue>), <elocation-id>e13032</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1111/aji.13032</pub-id><pub-id pub-id-type="pmid">30084522</pub-id><pub-id pub-id-type="pmcid">PMC6461368</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romero</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dey</surname><given-names>S. K.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>S. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Preterm Labor: One Syndrome, Many Causes</article-title>. <source>Sci. (80-. ).</source><volume>345</volume>, <fpage>760</fpage>&#8211;<lpage>765</lpage>. &#160;<pub-id pub-id-type="doi">10.1126/science.1251816</pub-id><pub-id pub-id-type="pmcid">PMC4191866</pub-id><pub-id pub-id-type="pmid">25124429</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romero</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gomez-Lopez</surname><given-names>N.</given-names></name><name name-style="western"><surname>Winters</surname><given-names>A. D.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>E.</given-names></name><name name-style="western"><surname>Shaman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bieda</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Evidence That Intra-Amniotic Infections Are Often the Result of an Ascending Invasion - A Molecular Microbiological Study</article-title>. <source>J. Perinat. Med.</source><volume>47</volume>, <fpage>915</fpage>&#8211;<lpage>931</lpage>. &#160;<pub-id pub-id-type="doi">10.1515/jpm-2019-0297</pub-id><pub-id pub-id-type="pmid">31693497</pub-id><pub-id pub-id-type="pmcid">PMC7147941</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Rosen</surname><given-names>G. H.</given-names></name><name name-style="western"><surname>Randis</surname><given-names>T. M.</given-names></name><name name-style="western"><surname>Desai</surname><given-names>P. V.</given-names></name><name name-style="western"><surname>Sapra</surname><given-names>K. J.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gajer</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Group B Streptococcus and the Vaginal Microbiota</article-title>. <source>J. Infect. Dis. (Oxford Univ. Press)</source>, <fpage>744</fpage>&#8211;<lpage>751</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/infdis/jix395</pub-id><pub-id pub-id-type="pmcid">PMC5853324</pub-id><pub-id pub-id-type="pmid">28934437</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>N. J.</given-names></name><name name-style="western"><surname>Seale</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>O&#8217;Driscoll</surname><given-names>M.</given-names></name><name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bianchi-Jassir</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gonzalez-Guarin</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-Analyses</article-title>. <source>Clin. Infect. Dis.</source><volume>65</volume>, <fpage>S100</fpage>&#8211;<lpage>S111</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/cid/cix658</pub-id><pub-id pub-id-type="pmid">29117327</pub-id><pub-id pub-id-type="pmcid">PMC5848259</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadowsky</surname><given-names>D. W.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Gravett</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Witkin</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Novy</surname><given-names>M. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Preterm Labor Is Induced by Intraamniotic Infusions of Interleukin-1&#946; and Tumor Necrosis Factor-&#945; But Not by Interleukin-6 or Interleukin-8 in a Nonhuman Primate Model</article-title>. <source>Am. J. Obstet. Gynecol.</source><volume>195</volume>, <fpage>1578</fpage>&#8211;<lpage>1589</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ajog.2006.06.072</pub-id><pub-id pub-id-type="pmid">17132473</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samen</surname><given-names>U.</given-names></name><name name-style="western"><surname>Eikmanns</surname><given-names>B. J.</given-names></name><name name-style="western"><surname>Reinscheid</surname><given-names>D. J.</given-names></name><name name-style="western"><surname>Borges</surname><given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>The Surface Protein Srr-1 of Streptococcus Agalactiae Binds Human Keratin 4 and Promotes Adherence to Epithelial HEp-2 Cells</article-title>. <source>Infect. Immun.</source><volume>75</volume>, <fpage>5405</fpage>&#8211;<lpage>5414</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/IAI.00717-07</pub-id><pub-id pub-id-type="pmid">17709412</pub-id><pub-id pub-id-type="pmcid">PMC2168289</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santi</surname><given-names>I.</given-names></name><name name-style="western"><surname>D</surname><given-names>M.</given-names></name><name name-style="western"><surname>CL</surname><given-names>G.</given-names></name><name name-style="western"><surname>G</surname><given-names>G.</given-names></name><name name-style="western"><surname>JL</surname><given-names>T.</given-names></name><name name-style="western"><surname>M</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>BibA Induces Opsonizing Antibodies Conferring <italic toggle="yes">In Vivo</italic> Protection Against Group B Streptococcus</article-title>. <source>J.&#160;Infect. Dis.</source><volume>200</volume>, <fpage>564</fpage>&#8211;<lpage>570</lpage>. &#160;<pub-id pub-id-type="doi">10.1086/603540</pub-id><pub-id pub-id-type="pmid">19586417</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santillan</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Andracki</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>S. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Protective Immunization in Mice Against Group B Streptococci Using Encapsulated C5a Peptidase</article-title>. <source>Am. J. Obstet. Gynecol.</source><volume>198</volume>, <fpage>114.e1</fpage>&#8211;<lpage>114.e6</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ajog.2007.06.003</pub-id><pub-id pub-id-type="pmid">17905172</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Santillan</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Rai</surname><given-names>K. K.</given-names></name><name name-style="western"><surname>Santillan</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Krishnamachari</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Salem</surname><given-names>A. K.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>S. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Efficacy of Polymeric Encapsulated C5a Peptidasebased Group B Streptococcus Vaccines in a Murine Model</article-title>. <source>Am. J. Obstetrics Gynecol. (Mosby Inc.)</source>, <fpage>249.e1</fpage>&#8211;<lpage>249.e8</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.ajog.2011.06.024</pub-id><pub-id pub-id-type="pmcid">PMC3213321</pub-id><pub-id pub-id-type="pmid">21802065</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Scarselli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mariani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pezzicoli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Masignani</surname><given-names>V.</given-names></name><name name-style="western"><surname>Taddei</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>BibA: A Novel Immunogenic Bacterial Adhesin Contributing to Group B Streptococcus Survival in Human Blood</article-title>. <source>Mol. Microbiol.</source><volume>63</volume>, <fpage>754</fpage>&#8211;<lpage>767</lpage>. &#160;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05555.x</pub-id><pub-id pub-id-type="pmid">17212592</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheibner</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>Lutz</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Boodoo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fenton</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Powell</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Horton</surname><given-names>M. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging Tlr2</article-title>. <source>J. Immunol.</source><volume>177</volume>, <fpage>1272</fpage>&#8211;<lpage>1281</lpage>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.177.2.1272</pub-id><pub-id pub-id-type="pmid">16818787</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schleimer</surname><given-names>R. P.</given-names></name><name name-style="western"><surname>Kato</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kern</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kuperman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Avila</surname><given-names>P. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Epithelium: At the Interface of Innate and Adaptive Immune Responses</article-title>. <source>J.&#160;Allergy Clin. Immunol.</source><volume>120</volume>, <fpage>1279</fpage>&#8211;<lpage>1284</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.jaci.2007.08.046</pub-id><pub-id pub-id-type="pmid">17949801</pub-id><pub-id pub-id-type="pmcid">PMC2810155</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seale</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Bianchi-Jassir</surname><given-names>F.</given-names></name><name name-style="western"><surname>Russell</surname><given-names>N. J.</given-names></name><name name-style="western"><surname>Kohli-Lynch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tann</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017</year>a). <article-title>Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children</article-title>. <source>Clin. Infect. Dis.</source><volume>65</volume>, <fpage>S200</fpage>&#8211;<lpage>S219</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/cid/cix664</pub-id><pub-id pub-id-type="pmid">29117332</pub-id><pub-id pub-id-type="pmcid">PMC5849940</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seale</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Blencowe</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bianchi-Jassir</surname><given-names>F.</given-names></name><name name-style="western"><surname>Embleton</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bassat</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ordi</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017</year>b). <article-title>Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-Analyses</article-title>. <source>Clin. Infect. Dis.</source><volume>65</volume>, <fpage>S125</fpage>&#8211;<lpage>S132</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/cid/cix585</pub-id><pub-id pub-id-type="pmid">29117322</pub-id><pub-id pub-id-type="pmcid">PMC5850020</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seo</surname><given-names>H. S.</given-names></name><name name-style="western"><surname>Minasov</surname><given-names>G.</given-names></name><name name-style="western"><surname>Seepersaud</surname><given-names>R.</given-names></name><name name-style="western"><surname>Doran</surname><given-names>K. S.</given-names></name><name name-style="western"><surname>Dubrovska</surname><given-names>I.</given-names></name><name name-style="western"><surname>Shuvalova</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Characterization of Fibrinogen Binding by Glycoproteins Srr1 and Srr2 of Streptococcus Agalactiae</article-title>. <source>J. Biol. Chem.</source><volume>288</volume>, <fpage>35982</fpage>&#8211;<lpage>35996</lpage>. &#160;<pub-id pub-id-type="doi">10.1074/jbc.M113.513358</pub-id><pub-id pub-id-type="pmid">24165132</pub-id><pub-id pub-id-type="pmcid">PMC3861647</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharpe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>V.</given-names></name><name name-style="western"><surname>Freire-Lizama</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cates</surname><given-names>E. C.</given-names></name><name name-style="western"><surname>McGrath</surname><given-names>K.</given-names></name><name name-style="western"><surname>David</surname><given-names>I.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Effectiveness of Oral Intake of Lactobacillus Rhamnosus GR-1 and Lactobacillus Reuteri RC-14 on Group B Streptococcus Colonization During Pregnancy: A Midwifery-Led Double-Blind Randomized Controlled Pilot Trial</article-title>. <source>J. Matern. Neonatal Med.</source><volume>34</volume>, <fpage>1814</fpage>&#8211;<lpage>1821</lpage>. &#160;<pub-id pub-id-type="doi">10.1080/14767058.2019.1650907</pub-id><pub-id pub-id-type="pmid">31362572</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheen</surname><given-names>T. R.</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N. Y.</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>A.</given-names></name><name name-style="western"><surname>van Sorge</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Doran</surname><given-names>K. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Serine-Rich Repeat Proteins and Pili Promote Streptococcus Agalactiae Colonization of the Vaginal Tract</article-title>. <source>J. Bacteriol.</source><volume>193</volume>, <fpage>6834</fpage>&#8211;<lpage>6842</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/JB.00094-11</pub-id><pub-id pub-id-type="pmid">21984789</pub-id><pub-id pub-id-type="pmcid">PMC3232834</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sitkiewicz</surname><given-names>I.</given-names></name><name name-style="western"><surname>Green</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bongiovanni</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Witkin</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Musser</surname><given-names>J. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Transcriptome Adaptation of Group B Streptococcus to Growth in Human Amniotic Fluid</article-title>. <source>PloS One</source><volume>4</volume> (<issue>7</issue>), <elocation-id>e6114</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0006114</pub-id><pub-id pub-id-type="pmid">19568429</pub-id><pub-id pub-id-type="pmcid">PMC2700258</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith-Dupont</surname><given-names>K. B.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>C. E.</given-names></name><name name-style="western"><surname>Witten</surname><given-names>J.</given-names></name><name name-style="western"><surname>Conroy</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rudoltz</surname><given-names>H.</given-names></name><name name-style="western"><surname>Pagidas</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Probing the Potential of Mucus Permeability to Signify Preterm Birth Risk</article-title>. <source>Sci. Rep.</source><volume>7</volume> (<issue>1</issue>), <fpage>10302</fpage>. &#160;<pub-id pub-id-type="doi">10.1038/s41598-017-08057-z</pub-id><pub-id pub-id-type="pmid">28871085</pub-id><pub-id pub-id-type="pmcid">PMC5583328</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soto</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Diaz-Dinamarca</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Soto</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Barrientos</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Carri&#243;n</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kalergis</surname><given-names>A. M.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Cellular Immune Response Induced by Surface Immunogenic Protein With AbISCO-100 Adjuvant Vaccination Decreases Group B Streptococcus Vaginal Colonization</article-title>. <source>Mol. Immunol.</source><volume>111</volume>, <fpage>198</fpage>&#8211;<lpage>204</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.molimm.2019.04.025</pub-id><pub-id pub-id-type="pmid">31078966</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sroka-Oleksiak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gosiewski</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pabian</surname><given-names>W.</given-names></name><name name-style="western"><surname>Gurgul</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kapusta</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ludwig-S&#322;omczy&#324;ska</surname><given-names>A. H.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Next-Generation Sequencing as a Tool to Detect Vaginal Microbiota Disturbances During Pregnancy</article-title>. <source>Microorganisms</source><volume>8</volume>, <fpage>1</fpage>&#8211;<lpage>15</lpage>. &#160;<pub-id pub-id-type="doi">10.3390/microorganisms8111813</pub-id><pub-id pub-id-type="pmcid">PMC7698737</pub-id><pub-id pub-id-type="pmid">33217908</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>St&#229;lhammar-Carlemalm</surname><given-names>M.</given-names></name><name name-style="western"><surname>Waldemarsson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Johnsson</surname><given-names>E.</given-names></name><name name-style="western"><surname>Areschoug</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lindahl</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Nonimmunodominant Regions Are Effective as Building Blocks in a Streptococcal Fusion Protein Vaccine</article-title>. <source>Cell Host Microbe</source><volume>2</volume>, <fpage>427</fpage>&#8211;<lpage>434</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.chom.2007.10.003</pub-id><pub-id pub-id-type="pmid">18078694</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sundrani</surname><given-names>D. P.</given-names></name><name name-style="western"><surname>Chavan-Gautam</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Pisal</surname><given-names>H. R.</given-names></name><name name-style="western"><surname>Mehendale</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>S. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Matrix Metalloproteinase-1 and -9 in Human Placenta During Spontaneous Vaginal Delivery and Caesarean Sectioning in Preterm Pregnancy</article-title>. <source>PloS One</source><volume>7</volume> (<issue>1</issue>), <elocation-id>e29855</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0029855</pub-id><pub-id pub-id-type="pmid">22253805</pub-id><pub-id pub-id-type="pmcid">PMC3257231</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ke</surname><given-names>B.</given-names></name><name name-style="western"><surname>He</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ning</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Inapparent Streptococcus Agalactiae Infection in Adult/Commercial Tilapia</article-title>. <source>Sci. Rep.</source><volume>6</volume>, <elocation-id>26319</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1038/srep26319</pub-id><pub-id pub-id-type="pmid">27215811</pub-id><pub-id pub-id-type="pmcid">PMC4877633</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutton</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>B. R. E. A.</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>L.</given-names></name><name name-style="western"><surname>Doster</surname><given-names>R.</given-names></name><name name-style="western"><surname>Algood</surname><given-names>H. M.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Protein Kinase D Mediates Inflammatory Responses of Human Placental Macrophages to Group B Streptococcus</article-title>. <source>Am. J. Reprod. Immunol.</source><volume>81</volume>. <pub-id pub-id-type="doi">10.1111/aji.13075</pub-id><pub-id pub-id-type="pmcid">PMC6459189</pub-id><pub-id pub-id-type="pmid">30582878</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swamy</surname><given-names>G. K.</given-names></name><name name-style="western"><surname>Metz</surname><given-names>T. D.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Soper</surname><given-names>D. E.</given-names></name><name name-style="western"><surname>Beigi</surname><given-names>R. H.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>J. D.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Safety and Immunogenicity of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Pregnant Women and Their Infants: Results From a Randomized Placebo-Controlled Phase II Trial</article-title>. <source>Vaccine</source><volume>38</volume>, <fpage>6930</fpage>&#8211;<lpage>6940</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.vaccine.2020.08.056</pub-id><pub-id pub-id-type="pmid">32883555</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sweeney</surname><given-names>E. L.</given-names></name><name name-style="western"><surname>Gardiner</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tickner</surname><given-names>J.</given-names></name><name name-style="western"><surname>Trim</surname><given-names>L.</given-names></name><name name-style="western"><surname>Beagley</surname><given-names>K. W.</given-names></name><name name-style="western"><surname>Carey</surname><given-names>A. J.</given-names></name></person-group> (<year>2020</year>). <article-title>Group B Streptococcus Serotypes Ia and V Induce Differential Vaginal Immune Responses That may Contribute to Long Term Colonization of the Female Reproductive Tract</article-title>. <source>Am. J. Reprod. Immunol.</source><volume>83</volume> (<issue>1</issue>), <elocation-id>e13199</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1111/aji.13199</pub-id><pub-id pub-id-type="pmid">31626718</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Aoyagi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Adderson</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Okuwaki</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bohnsack</surname><given-names>J. F.</given-names></name></person-group> (<year>1999</year>). <article-title>Capsular Sialic Acid Limits C5a Production on Type III Group B Streptococci</article-title>. <source>Infect. Immun.</source><volume>67</volume>, <fpage>1866</fpage>&#8211;<lpage>1870</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/iai.67.4.1866-1870.1999</pub-id><pub-id pub-id-type="pmid">10085029</pub-id><pub-id pub-id-type="pmcid">PMC96539</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tambor</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kacerovsky</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lenco</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>G.</given-names></name><name name-style="western"><surname>Menon</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Proteomics and Bioinformatics Analysis Reveal Underlying Pathways of Infection Associated Histologic Chorioamnionitis in pPROM</article-title>. <source>Placenta</source><volume>34</volume>, <fpage>155</fpage>&#8211;<lpage>161</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.placenta.2012.11.028</pub-id><pub-id pub-id-type="pmid">23246098</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>K. R.</given-names></name><name name-style="western"><surname>Trowbridge</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Rudisill</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Termeer</surname><given-names>C. C.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>R. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Hyaluronan Fragments Stimulate Endothelial Recognition of Injury Through TLR4</article-title>. <source>J. Biol. Chem.</source><volume>279</volume>, <fpage>17079</fpage>&#8211;<lpage>17084</lpage>. &#160;<pub-id pub-id-type="doi">10.1074/jbc.M310859200</pub-id><pub-id pub-id-type="pmid">14764599</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tazi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Disson</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bellais</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bouaboud</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dmytruk</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dramsi</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>The Surface Protein HvgA Mediates Group B Streptococcus Hypervirulence and Meningeal Tropism in Neonates</article-title>. <source>J. Exp. Med.</source><volume>207</volume>, <fpage>2313</fpage>&#8211;<lpage>2322</lpage>. &#160;<pub-id pub-id-type="doi">10.1084/jem.20092594</pub-id><pub-id pub-id-type="pmid">20956545</pub-id><pub-id pub-id-type="pmcid">PMC2964583</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teatero</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ramoutar</surname><given-names>E.</given-names></name><name name-style="western"><surname>McGeer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>A.</given-names></name><name name-style="western"><surname>Melano</surname><given-names>R. G.</given-names></name><name name-style="western"><surname>Wasserscheid</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Clonal Complex 17 Group B Streptococcus Strains Causing Invasive Disease in Neonates and Adults Originate From the Same Genetic Pool</article-title>. <source>Sci. Rep.</source><volume>6</volume>, <elocation-id>20047</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1038/srep20047</pub-id><pub-id pub-id-type="pmid">26843175</pub-id><pub-id pub-id-type="pmcid">PMC4740736</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Termeer</surname><given-names>C.</given-names></name><name name-style="western"><surname>Benedix</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sleeman</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fieber</surname><given-names>C.</given-names></name><name name-style="western"><surname>Voith</surname><given-names>U.</given-names></name><name name-style="western"><surname>Ahrens</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Oligosaccharides of Hyaluronan Activate Dendritic Cells <italic toggle="yes">via</italic> Toll-Like Receptor 4</article-title>. <source>J. Exp. Med.</source><volume>195</volume>, <fpage>99</fpage>&#8211;<lpage>111</lpage>. &#160;<pub-id pub-id-type="doi">10.1084/jem.20001858</pub-id><pub-id pub-id-type="pmid">11781369</pub-id><pub-id pub-id-type="pmcid">PMC2196009</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>M. Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L. C.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H. R.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Molecular Characteristics and Antimicrobial Resistance of Group B Streptococcus Strains Causing Invasive Disease in Neonates and Adults</article-title>. <source>Front. Microbiol.</source><volume>10</volume>, <elocation-id>264</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fmicb.2019.00264</pub-id><pub-id pub-id-type="pmid">30833941</pub-id><pub-id pub-id-type="pmcid">PMC6387999</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uchiyama</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fukahori</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ando</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Dual Actions of Group B Streptococcus Capsular Sialic Acid Provide Resistance to Platelet-Mediated Antimicrobial Killing</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>116</volume>, <fpage>7465</fpage>&#8211;<lpage>7470</lpage>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1815572116</pub-id><pub-id pub-id-type="pmid">30910970</pub-id><pub-id pub-id-type="pmcid">PMC6462088</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vanderhoeven</surname><given-names>J. P.</given-names></name><name name-style="western"><surname>Bierle</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Kapur</surname><given-names>R. P.</given-names></name><name name-style="western"><surname>McAdams</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Beyer</surname><given-names>R. P.</given-names></name><name name-style="western"><surname>Bammler</surname><given-names>T. K.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Group B Streptococcal Infection of the Choriodecidua Induces Dysfunction of the Cytokeratin Network in Amniotic Epithelium: A Pathway to Membrane Weakening</article-title>. <source>PloS Pathog.</source><volume>10</volume> (<issue>3</issue>), <elocation-id>e1003920</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1371/journal.ppat.1003920</pub-id><pub-id pub-id-type="pmid">24603861</pub-id><pub-id pub-id-type="pmcid">PMC3946355</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Sorge</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Bonsor</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lindahl</surname><given-names>E.</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>V.</given-names></name><name name-style="western"><surname>Lyndin</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Bacterial Protein Domains With a Novel Ig-Like Fold Target Human CEACAM Receptors</article-title>. <source>EMBO J.</source><volume>40</volume> (<issue>7</issue>), <elocation-id>e106103</elocation-id>. &#160;<pub-id pub-id-type="doi">10.15252/embj.2020106103</pub-id><pub-id pub-id-type="pmid">33522633</pub-id><pub-id pub-id-type="pmcid">PMC8013792</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vornhagen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Armistead</surname><given-names>B.</given-names></name><name name-style="western"><surname>Santana-Ufret</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gendrin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Merillat</surname><given-names>S.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2018</year>a). <article-title>Group B Streptococcus Exploits Vaginal Epithelial Exfoliation for Ascending Infection</article-title>. <source>J. Clin. Invest.</source><volume>128</volume>, <fpage>1985</fpage>&#8211;<lpage>1999</lpage>. &#160;<pub-id pub-id-type="doi">10.1172/JCI97043</pub-id><pub-id pub-id-type="pmid">29629904</pub-id><pub-id pub-id-type="pmcid">PMC5919824</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vornhagen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Quach</surname><given-names>P.</given-names></name><name name-style="western"><surname>Boldenow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Merillat</surname><given-names>S.</given-names></name><name name-style="western"><surname>Whidbey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>L. Y.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Bacterial Hyaluronidase Promotes Ascending GBS Infection and Preterm Birth</article-title>. <source>MBio.</source><volume>7</volume> (<issue>3</issue>):<page-range>e00781&#8211;16</page-range>. &#160;<pub-id pub-id-type="doi">10.1128/mBio.00781-16</pub-id><pub-id pub-id-type="pmcid">PMC4937215</pub-id><pub-id pub-id-type="pmid">27353757</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vornhagen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Quach</surname><given-names>P.</given-names></name><name name-style="western"><surname>Santana-Ufret</surname><given-names>V.</given-names></name><name name-style="western"><surname>Alishetti</surname><given-names>V.</given-names></name><name name-style="western"><surname>Brokaw</surname><given-names>A.</given-names></name><name name-style="western"><surname>Armistead</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2018</year>b). <article-title>Human Cervical Mucus Plugs Exhibit Insufficiencies in Antimicrobial Activity Towards Group B Streptococcus</article-title>. <source>J. Infect. Dis.</source><volume>217</volume>, <fpage>1626</fpage>&#8211;<lpage>1636</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/infdis/jiy076</pub-id><pub-id pub-id-type="pmid">29425317</pub-id><pub-id pub-id-type="pmcid">PMC5913629</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vrbanac</surname><given-names>A.</given-names></name><name name-style="western"><surname>Riestra</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Coady</surname><given-names>A.</given-names></name><name name-style="western"><surname>Knight</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name><name name-style="western"><surname>Patras</surname><given-names>K. A.</given-names></name></person-group> (<year>2018</year>). <article-title>The Murine Vaginal Microbiota and Its Perturbation by the Human Pathogen Group B Streptococcus</article-title>. <source>BMC Microbiol.</source><volume>18</volume> (<issue>1</issue>), <fpage>197</fpage>. &#160;<pub-id pub-id-type="doi">10.1186/s12866-018-1341-2</pub-id><pub-id pub-id-type="pmid">30477439</pub-id><pub-id pub-id-type="pmcid">PMC6260558</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>S. W.</given-names></name><name name-style="western"><surname>Nugent</surname><given-names>W. H.</given-names></name><name name-style="western"><surname>Solotskaya</surname><given-names>A. V.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Grider</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Strauss</surname><given-names>J. F.</given-names></name></person-group> (<year>2018</year>). <article-title>Matrix Metalloprotease-1 and Elastase Are Novel Uterotonic Agents Acting Through Protease-Activated Receptor 1</article-title>. <source>Reprod. Sci.</source><volume>25</volume>, <fpage>1058</fpage>&#8211;<lpage>1066</lpage>. &#160;<pub-id pub-id-type="doi">10.1177/1933719117732162</pub-id><pub-id pub-id-type="pmid">28954603</pub-id><pub-id pub-id-type="pmcid">PMC6346347</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>N. Y.</given-names></name><name name-style="western"><surname>Patras</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>Seo</surname><given-names>H. S.</given-names></name><name name-style="western"><surname>Cavaco</surname><given-names>C. K.</given-names></name><name name-style="western"><surname>R&#246;sler</surname><given-names>B.</given-names></name><name name-style="western"><surname>Neely</surname><given-names>M. N.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Group B Streptococcal Serine-Rich Repeat Proteins Promote Interaction With Fibrinogen and Vaginal Colonization</article-title>. <source>J. Infect. Dis. (Oxford Univ. Press)</source><volume>210</volume> (<issue>6</issue>), <fpage>982</fpage>&#8211;<lpage>991</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/infdis/jiu151</pub-id><pub-id pub-id-type="pmcid">PMC4192050</pub-id><pub-id pub-id-type="pmid">24620021</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weed</surname><given-names>S.</given-names></name><name name-style="western"><surname>Armistead</surname><given-names>B.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Denny Liggit</surname><given-names>H.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>MicroRNA Signature of Epithelial-Mesenchymal Transition in Group B Streptococcal Infection of the Placental Chorioamniotic Membranes</article-title>. <source>J.&#160;Infect. Dis.</source><volume>222</volume>, <fpage>1713</fpage>&#8211;<lpage>1722</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/infdis/jiaa280</pub-id><pub-id pub-id-type="pmid">32453818</pub-id><pub-id pub-id-type="pmcid">PMC7751568</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Uchiyama</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>F. Y. C.</given-names></name><name name-style="western"><surname>Chaffin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Varki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>O-Acetylation of Sialic Acid on Group B Streptococcus Inhibits Neutrophil Suppression and Virulence</article-title>. <source>Biochem. J.</source><volume>428</volume>, <fpage>163</fpage>&#8211;<lpage>168</lpage>. &#160;<pub-id pub-id-type="doi">10.1042/BJ20100232</pub-id><pub-id pub-id-type="pmid">20334627</pub-id><pub-id pub-id-type="pmcid">PMC3640289</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whidbey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Harrell</surname><given-names>M. I.</given-names></name><name name-style="western"><surname>Burnside</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Becraft</surname><given-names>A. K.</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>L. M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>A Hemolytic Pigment of Group B Streptococcus Allows Bacterial Penetration of Human Placenta</article-title>. <source>J. Exp. Med.</source><volume>210</volume>, <fpage>1265</fpage>&#8211;<lpage>1281</lpage>. &#160;<pub-id pub-id-type="doi">10.1084/jem.20122753</pub-id><pub-id pub-id-type="pmid">23712433</pub-id><pub-id pub-id-type="pmcid">PMC3674703</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whidbey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vornhagen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gendrin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Boldenow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Samson</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Doering</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>A Streptococcal Lipid Toxin Induces Membrane Permeabilization and Pyroptosis Leading to Fetal Injury</article-title>. <source>EMBO Mol. Med.</source><volume>7</volume>, <fpage>488</fpage>&#8211;<lpage>505</lpage>. &#160;<pub-id pub-id-type="doi">10.15252/emmm.201404883</pub-id><pub-id pub-id-type="pmid">25750210</pub-id><pub-id pub-id-type="pmcid">PMC4403049</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>